<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>   <meta charset="utf-8" />
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 10">
<meta name=Originator content="Microsoft Word 10">
<base target="_blank">
<link rel=File-List href="uyku_dosyalar/filelist.xml">
<title>UYKU HASTALIKLARI</title>
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Calibri;
	mso-font-alt:"Times New Roman";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:auto;
	mso-font-signature:0 0 0 0 0 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
span.char1
	{mso-style-name:char1;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
span.char3
	{mso-style-name:char3;
	font-weight:bold;}
span.msons
	{mso-style-name:mso\0131ns;
	text-decoration:underline;
	text-underline:single;}
span.msodel0
	{mso-style-name:msodel;
	color:red;
	text-decoration:line-through;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:70.85pt 70.85pt 70.85pt 70.85pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Normal Tablo";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";}
</style>
<![endif]-->
</head>

<body lang=EN-US link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal><b><span lang=TR style='font-size:16.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>UYKU HASTALIKLARI</span></b><span
lang=FR style='mso-ansi-language:FR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Candan G�rses</span></b><span lang=FR
style='mso-ansi-language:FR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>G�ncelleme tarihi: 25.12.2009</span><span
lang=FR style='mso-ansi-language:FR'><o:p></o:p></span></p>

</div>

<p class=MsoNormal><b><span lang=TR style='font-size:14.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>GENEL B&#304;LG&#304;LER</span></b><span
lang=FR style='mso-ansi-language:FR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Uyku merkezi sinir sisteminin (MSS)
yan&#305; s&#305;ra, hemodinamik, ventilat�r ve metabolik parametrelerin
dinamik dalgalanmalar g�sterdi&#287;i aktif fizyolojik bir durumdur.
&nbsp;T�rden t�re de&#287;i&#351;en karakteristikleri olan uyku, d&#305;&#351;
uyaranlara cevap e&#351;i&#287;inin y�kseldi&#287;i ve �zel bir post�rde sakin
ge�irilen bir s�redir. Bu kompleks davran&#305;&#351; kendine �zel
elektrofizyolojik bulgular&#305; olan bir s�re�tir.</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Yunan mitolojisinde uyku ile �l�m
aras&#305;nda fark olmad&#305;&#287;&#305; belirtilir. Uyku ve r�yalar&#305;n
bir�ok tanr&#305;s&#305; tan&#305;mlanm&#305;&#351;t&#305;r. Gecenin
tanr&#305;�as&#305; <i>Nyks</i> ve onun �ocuklar&#305; uyku tanr&#305;s&#305; <i>Hypnos</i>
ve �l�m tanr&#305;s&#305; <i>Thanatos</i> idi. Hypnos karanl&#305;k vadilerde
g�ne&#351; &#305;&#351;&#305;&#287;&#305;n&#305;n girmedi&#287;i yerlerde
ya&#351;ard&#305;. Hypnos�un <i>Morpheus, Phobetor</i> ve <i>Phantasos</i>
isimli �� o&#287;lu vard&#305;. Morpheus babas&#305; Hypnos�u kanatlar&#305;nda
ta&#351;&#305;yarak insanlar&#305;n r�ya g�rmesine ve uykuya girmelerine
yard&#305;mc&#305; olurdu.&nbsp; Morpheus r�ya
yarat&#305;c&#305;l&#305;&#287;&#305;ndan sorumluydu ve bu r�yalar&#305;n
i�eri&#287;ini di&#287;er karde&#351;lerine g�nderirdi. Bu iki karde&#351;i
Morpheus�un r�ya d�nyas&#305;nda ya&#351;arlard&#305;. Phantasos cans&#305;z
objelerden sorumluyken, Phobetor bunlar&#305;n canl&#305;lara, &nbsp;insan ve
hayvanlara d�n�&#351;mesini sa&#287;lard&#305;. Morpheus �zellikle kral ve
kahramanlar&#305;n r�yalar&#305;ndan sorumluydu. Phantasos fantastik r�yalar, Phobetor
ise kabuslar&#305;n g�r�lmesini sa&#287;lard&#305;. Morfin ad&#305;n&#305;
Morpheus�tan ve onun r�ya g�rmeye neden olan g�c�nden al&#305;r. Fobi
ad&#305;n&#305; kabus g�rmeye neden olan tanr&#305; Phobetor�dan al&#305;rken,
Phantasos ise fantazi kavram&#305; ile e&#351;le&#351;mi&#351;tir. 1834
y&#305;l&#305;nda �uykunun filozofisi� ad&#305;nda bir kitap yazm&#305;&#351;
olan Robert MacNish�e g�re uyku, uyan&#305;kl&#305;k ile �l�m aras&#305;ndaki
bir ge�i&#351; d�nemini g�stermektedir. B�y�k d�&#351;�n�rlerden Aristo,
Hipokrat, Freud ve Pavlov da uyku ve r�yalar �zerine fizyolojik ve psikolojik
a�&#305;klamalar yapmaya �al&#305;&#351;m&#305;&#351;lard&#305;r. Uykunun
bilinmezli&#287;i ge�en y�zy&#305;l&#305;n ortas&#305;na do&#287;ru yava&#351;
yava&#351; aralanmaya ba&#351;lam&#305;&#351;t&#305;r. Yap&#305;lan �ok
say&#305;da yay&#305;n ile bu bilinmezlikler giderek azalt&#305;lmaya
�al&#305;&#351;&#305;lmaktad&#305;r.&nbsp; </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Ge�en y�zy&#305;l&#305;n ikinci
yar&#305;s&#305;nda uyku ile ilgili �nemli ke&#351;ifler oldu. Bunlar&#305;n en
�nemlisi ise uykunun yava&#351; g�z hareketi (non-rapid eye movement, <i>NREM</i>)
ve h&#305;zl&#305; g�z hareketi (rapid eye movement, <i>REM</i>) olmak �zere
iki b�l�mden olu&#351;tu&#287;unun g�sterilmesidir. Ya&#351;am, sonu�ta ��
evreden, uyan&#305;kl&#305;k, REM ve NREM�den olu&#351;maktad&#305;r. Her
evrenin kendine �zg� n�roanatomik, n�rofizyolojik ve n�rofarmakolojik
�zellikleri vard&#305;r. Bu evreler i�in bilinen spesifik b�lgeler yoktur.
Uyan&#305;kl&#305;k jenerat�r olarak beyinsap&#305;nda retik�ler aktive edici
sistemde lokalize iken, NREM uykusunun bulbus ve �nbeyin b�lgesinde ve REM
uykusunun da ponsta oldu&#287;u s�ylenebilir. Ponsta vestib�ler �ekirdeklerin
REM uykusunun olu&#351;umunu ve �perilocus coeruleus�un ise atoniyi
sa&#287;lad&#305;&#287;&#305; bildirilmektedir. Ancak yukar&#305;da belirtilen
b�lgeler bu evrelerin fonksiyonlar&#305;n&#305; tam a�&#305;klamaya
yetmemektedir. Uyku s&#305;ras&#305;nda MSS�de yayg&#305;n reorganizasyon devam
eder. Ayn&#305; anatomik b�lgenin stim�lasyonu ile uyan&#305;kl&#305;k ve REM
uykusu d�nemlerinde motor aktivite �zerine birbirinden farkl&#305; etkiler olu&#351;turur.
REM uykusundaki en �arp&#305;c&#305; bulgulardan biri, duruma ba&#287;l&#305;
olarak diyafram ve ekstraok�ler kaslar hari�, t�m kaslar&#305;n aktif
paralizisidir. Beyinsap&#305; inhibit�r sistemleri hem motor eksitat�r sistemi
bask&#305;lar hem de direkt olarak spinal motorn�ronlar&#305; inhibe eder.
Duysal deaferentasyon uykuda s&#305;kl&#305;kla �nko&#351;ul olarak
d�&#351;�n�l�r. NREM uykuda talamus �relay� modundan (duysal uyaran&#305;n
hemisferlere ula&#351;mas&#305;na izin verilme d�nemi) �osilat�r� moduna
(duysal uyaran&#305;n ge�i&#351;ini �nleme d�nemi) �evrilir. NREM�de talamik
retik�ler �ekirdek uyku i&#287;ciklerinin olu&#351;umundan sorumludur. NREM
evre 3-4�deki yava&#351; dalgalar hem talamus hem de korteks taraf&#305;ndan
olu&#351;turulur. Ancak REM uykusunda talamus tekrar �osilat�r� moddan �relay�
moda d�ner. REM uykusunda aynen uyan&#305;kl&#305;ktaki gibi duysal
uyaranlar&#305;n ge�i&#351;i vard&#305;r, ancak korteks bu uyaranlar&#305;
de&#287;erlendirmeye almaz. R�yalarda a&#287;r&#305;n&#305;n
alg&#305;lanmas&#305;n&#305;n azl&#305;&#287;&#305; ile ilgili olarak,
spinoretik�ler traktus aktivitesinin azalmas&#305;nda REM uykusunun
katk&#305;s&#305; tart&#305;&#351;&#305;lmaktad&#305;r. N�rofizyolojik bulgular
a�&#305;s&#305;ndan da bak&#305;l&#305;nca REM uykusu ile uyan&#305;kl&#305;k
aras&#305;nda �ok benzerlik vard&#305;r. Asendan retik�ler aktive edici sistem
her iki d�nemde de hem talamusun hem de korteksin etkinli&#287;ini
potansiyelize eder. Elektroensefalogram (EEG), uyan&#305;kl&#305;k ve REM
uykusunda desenkronize iken NREM uykusunda senkronizedir. NREM d�rt evreden
olu&#351;ur. Evre 1-2 hafif uyku ve evre 3-4 derin veya yava&#351; dalga uykusu
olarak isimlendirilir. NREM�i takiben REM uykusu ba&#351;lar ve gecede 4-5
siklus ya&#351;an&#305;r.&nbsp; REM uykusu ise d�&#351;�k amplit�dl� ve y�ksek
frekansl&#305; olmas&#305; nedeniyle uyan&#305;kl&#305;&#287;a benzer. REM
uykusunun uyan&#305;kl&#305;ktan fark&#305; kas tonusu kayb&#305;, arada nadir
kas se&#287;irmesi, h&#305;zl&#305; g�z hareketleri, solunumun ve kalp
h&#305;z&#305;n&#305;n d�zensizli&#287;i ile otonomik bulgular&#305;n
olmas&#305;d&#305;r. Tonik ve fazik olmak �zere iki alt tipe ayr&#305;l&#305;r.
Fazik aktivite s&#305;ras&#305;nda h&#305;zl&#305; g�z hareketleri ba&#351;lar,
distal kaslarda se&#287;irme, orta kulak kas aktivitesinde artma olur. REM
uykusunda g�r�len ponto-genikulo-oksipital dalgalar genellikle insanlarda
kay&#305;tlanamaz. R�yalar&#305;n %80�i REM uykusunda g�r�l�r.&nbsp; Uykunun
kontrol�nden sorumlu olan iki mekanizma tan&#305;mlanm&#305;&#351;t&#305;r.
Bunlar homeostatik ve sirkadyen mekanizmalard&#305;r. Bu mekanizmalar&#305;n
hen�z tam anla&#351;&#305;lamamas&#305; nedeniyle uyku paralizisi, katapleksi,
somnambulizm, REM uyku davran&#305;&#351; bozuklu&#287;u gibi �ok farkl&#305;
ve renkli klinik bulgu ve hastal&#305;klar&#305;n patofizyolojisini
bilememekteyiz.</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Uyku ve uyan&#305;kl&#305;k
paternindeki maj�r de&#287;i&#351;iklikler ki&#351;inin ya&#351;am&#305;
boyunca devam eder. Ya&#351;la ili&#351;kili olarak hem uyku
uyan&#305;kl&#305;k siklusu hem de uykunun i�indeki uyku evrelerinin
da&#287;&#305;l&#305;m&#305; de&#287;i&#351;ir. Ya&#351;a g�re uykunun
geli&#351;imine bak&#305;lacak olursa, yenido&#287;an ya&#351;am&#305;n ilk
haftalar&#305;nda g�n�n 2/3�n� uyuyarak ge�irir. Bu polifazik uyku paterni
eri&#351;kin monofazik yap&#305;s&#305;na yava&#351; yava&#351; ge�er.
Yenido&#287;an g�nde 16-20 saat aras&#305;ndaki s�reyi uykuda ge�irirken
�ocukta bu s�re 10-12 saattir; ergen ve eri&#351;kinde 7-7.5 saat ve
ya&#351;l&#305; ki&#351;ilerde 6.5 saate kadar iner. Normal ki&#351;ilerde
toplam uyku s�resi 4-10 saat aras&#305;d&#305;r. Uyku s�resi ki&#351;inin
genetik olarak uykuya ihtiyac&#305;na g�re belirlenir. Baz&#305;
eri&#351;kinlerde �&#287;leden sonra uykusu devam eder. Uyku
uyan&#305;kl&#305;k siklusunu ya&#351;a g�re de&#287;erlendirirsek,
yenido&#287;anda uyku gece boyunca d�zensiz olarak kesintili iken d�rt
ya&#351;&#305;ndaki �ocukta art&#305;k kesintisiz gece uykusu ve g�nd�z bir kez
k&#305;sa s�reli uyku vard&#305;r. &#304;lerleyen ya&#351;larda �nce k&#305;sa
s�reli g�nd�z uykular&#305; kaybolur, sonra gece uykular&#305;n&#305;n
saatlerinde azalma ba&#351;lar.&nbsp; Yenido&#287;anda EEG bulgular&#305;, g�z,
v�cut hareketleri ve solunum paterni ile uyku-uyan&#305;kl&#305;k ay&#305;rt
edilmeye �al&#305;&#351;&#305;l&#305;r. Uyku REM veya aktif uyku ile
ba&#351;lar. NREM veya inaktif uykuyla devam eder.&nbsp; Kol, bacak ve y�z
kaslar&#305;n&#305;n spontan hareketi bu aktif uykuyla bir arada g�r�lebilir.
Premat�relerde ise (&lt;37 hafta) REM uykusunu uyan&#305;kl&#305;ktan
ay&#305;rt etmek zor olabilir. Yenido&#287;anda REM ve NREM uyku s�releri e&#351;ittir.
Uyku uyan&#305;kl&#305;k 3-4 saatte bir d�n�&#351;�ml� olarak birbirini izler.
&#304;lerleyen haftalarda gece-g�nd�z siklusuna uyum olu&#351;ur.
Is&#305;n&#305;n sirkadyen ritminin g�r�lmesi �nemlidir. &#304;lerleyen aylarda
REM uykusunun uyku i�indeki oran&#305; giderek azalmaya ve uykunun daha �ok
ikinci yar&#305;s&#305;nda ortaya �&#305;kmaya ba&#351;lar. NREM uykusu ise
�o&#287;unlukla uykunun ilk yar&#305;s&#305;nda g�r�l�r. Uyku siklusu (NREM ve
REM uykusu) ya&#351;am&#305;n ilk y&#305;llar&#305;nda 60-70 dakikad&#305;r.
Verteks keskin dalgalar&#305; genellikle 5. ayda g�r�lmeye ba&#351;lar, ilk
aylarda rudimenterdir. &nbsp;D�rd�nc� haftadan itibaren uyku i&#287;cikleri
g�r�lmeye ba&#351;lar, 6. ayda uyku i&#287;ciklerinin say&#305;s&#305;
artm&#305;&#351;, ancak hala hemisferler aras&#305; asenkroni g�stermektedir.
&#304;ki ya&#351;&#305;ndan sonra asimetri beklenmez. K kompleksleri 3. aydan
itibaren ba&#351;lar ve 2 ya&#351;&#305;nda geli&#351;imini tamamlar. NREM evre
4, 6-12. ay aras&#305;nda izlenmeye ba&#351;lar. REM uykusu ise 3. ayda
elektrofizyolojik olarak belirmeye ba&#351;lar (Eri&#351;kinlerdeki uykunun
elektrofizyolojik �zellikleri i�in ayr&#305;ca kitab&#305;n N�roloji�de
laboratuar incelemeleri; EEG b�l�m�ne bak&#305;n&#305;z). Eri&#351;kinde uyku
NREM ile ba&#351;lar. &nbsp;Uykuya giri&#351;te (NREM evre 1) alfa
dalgalar&#305;n&#305;n amplit�d� yava&#351; yava&#351; d�&#351;er ve yava&#351;
dalgalar aral&#305;kl&#305; olarak g�r�lmeye ba&#351;lar. &#304;lerleyen
dakikalarda g�z hareketleri yava&#351;lar, h&#305;zl&#305; ritimler artar. POST
(positive occipital sharp transients of sleep) g�r�lebilir. POST, bilateral
oksipital b�lgede 4-5 Hz frekans&#305;ndad&#305;r, ancak genellikle asimetrik
olarak ortaya �&#305;kar (<b>&#350;ekil 1</b>). Keskin karakterli oldu&#287;u
i�in �o&#287;unlukla (hatal&#305; olarak) anormal olarak
de&#287;erlendirilebilen bu dalgalar, NREM evre 1�de g�r�l�r. NREM evre 1,
uykunun %2-5�ni olu&#351;turur. &nbsp;NREM evre 2�de uyku i&#287;cikleri, K
kompleksleri ve verteks keskin dalgalar&#305; g�r�l�r (<b>&#350;ekil 2</b>).
Uyku i&#287;cikleri 0.5-1.5 sn s�ren, 12-14 Hz frekans&#305;nda
osilasyonlard&#305;r. K kompleksleri ise y�ksek amplit�dl�, bifazik, en az 0.5
sn s�ren pozitif defleksiyonu takiben negatif defleksiyonlardan olu&#351;an
yava&#351; dalgalard&#305;r. Verteks keskin dalgalar&#305; k&#305;sa s�reli
y�ksek amplit�dl� negatif dalgalard&#305;r. Santral b�lgelerde belirgindir.
NREM evre 2 uykunun %45-55�ni meydana getirir. NREM evre 3 derin uykuya
giri&#351;tir, EEG�deki frekanslar daha da yava&#351;lam&#305;&#351; olarak
izlenir. K kompleksleri ve daha az miktarda uyku i&#287;cikleri g�r�l�r.
Uykunun %3-8�ni olu&#351;turur. NREM evre 4�de ise yava&#351; dalgalar genel karakteristi&#287;ini
olu&#351;turur ve az miktarda K kompleksleri belirir (<b>&#350;ekil 3</b>). Bu
evre uykunun %10-15�inden sorumludur. REM uykusu NREM evre 1�e benzer. Gecenin
ikinci yar&#305;s&#305;ndan sonra uyku daha �ok REM
a&#287;&#305;rl&#305;kl&#305; olur. Amplit�d d�&#351;er, yava&#351; dalga
frekans&#305; hakimdir ve kas tonusu s�prese (atoni) olmu&#351;tur.
H&#305;zl&#305; g�z hareketleri izlenir (<b>&#350;ekil 4</b>). �Sawtooth�
dalgalar&#305; 3-7 Hz frekans&#305;nda olup testereye benzedi&#287;i i�in bu ad
verilmi&#351;tir. (<b>&#350;ekil 5</b>). Uykunun %75-80�ini &nbsp;NREM uykusu
ve %20-25�ini REM uykusu olu&#351;turur. Eri&#351;kinlerde uyku siklusu 90
dakikad&#305;r ve gece uykusunda 5-7 uyku siklusu g�r�l�r. Uyku NREM ile
ba&#351;lar. Uyku sadece makro (NREM-REM) yap&#305;lanmadan
olu&#351;mamaktad&#305;r, mikro yap&#305;lanmas&#305; da vard&#305;r. &#304;lk
kez Terzano taraf&#305;ndan tarif edilen �siklik alternan patern�
�o&#287;unlukla NREM uykuda belirir. Derin uykunun ge�ici olarak
hafifledi&#287;i d�nemlerde, aferent uyaranlardan ba&#287;&#305;ms&#305;z
olarak olu&#351;ur. A ve B faz&#305; vard&#305;r. Her faz 2-60 saniye s�rer.
Makro uykunun yap&#305;sal parametrelerinde uyku hastal&#305;&#287;&#305;
olanlar ve normal ki&#351;iler aras&#305;nda farkl&#305;l&#305;k g�r�lmez iken
�siklik alternan patern� uyku hastal&#305;&#287;&#305; olanlarda artar. Uykunun
fonksiyonlar&#305;n&#305; hen�z tam bilmiyoruz, ancak hayvan deneylerinden elde
edilen sonu�lara g�re total NREM ve REM deprivasyonu 3 hafta i�inde veya izole
REM deprivasyonu alt&#305; hafta i�inde fatal seyreder. �l�mlerin
mekanizmas&#305; tam anla&#351;&#305;lamam&#305;&#351;t&#305;r. Ba&#351;ka bir
bulgu ise uyku deprivasyonu yap&#305;lm&#305;&#351; ki&#351;ilerde deprivasyon
sonras&#305; d�nemde NREM evre 3-4 uykusunun tamam&#305; ve REM uykusunun
%50�si nin yerine konmas&#305;d&#305;r. </span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Uykunun olas&#305; fonksiyonlar&#305;:
1- yenilenme, 2-enerjiyi koruma, 3-ya&#351;lanma s�recine diren� (foraging),
4-imm�nolojik, 5-termoreg�lasyon, 6-�nemli beyin b�lgelerinin korunmas&#305;,
7-korneal anoksinin �nlenmesi, 8- n�ronal b�t�nl�&#287;�n�n devam&#305;n&#305;
sa&#287;lamakt&#305;r. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;color:blue;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><b><u><span lang=TR style='font-size:10.0pt;line-height:115%;font-family:
Tahoma;color:#003399;mso-ansi-language:TR'><a href="uyku1.jpg">&#350;ekil 1<span
style='font-weight:normal'>.</span></a></span></u></b><span lang=TR
style='font-size:10.0pt;line-height:115%;font-family:Tahoma;color:blue;
mso-ansi-language:TR'> </span><span lang=TR style='font-size:10.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>NREM evre 1 POST dalgalar&#305;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;color:blue;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><b><u><span lang=TR style='font-size:10.0pt;line-height:115%;font-family:
Tahoma;color:#003399;mso-ansi-language:TR'><a href="uyku2.jpg">&#350;ekil 2<span
style='font-weight:normal'>.</span></a></span></u></b><span lang=TR
style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>NREM evre 2 uyku i&#287;cikleri ve verteks keskin dalgalar&#305;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-indent:35.4pt'><b><u><span lang=TR
style='font-size:10.0pt;line-height:115%;font-family:Tahoma;color:#003399;
mso-ansi-language:TR'><a href="uyku3.jpg">&#350;ekil 3<span style='font-weight:
normal'>. </span></a></span></u></b><span lang=TR style='font-size:10.0pt;
line-height:115%;font-family:Tahoma;mso-ansi-language:TR'>&nbsp;NREM evre 4</span></p>

<p class=MsoNormal style='text-indent:35.4pt'><b><u><span lang=TR
style='font-size:10.0pt;line-height:115%;font-family:Tahoma;color:#003399;
mso-ansi-language:TR'><a href="uyku4.jpg">&#350;ekil 4.</a></span></u></b><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> REM uykusu h&#305;zl&#305; g�z hareketleri </span></p>

<p class=MsoNormal style='text-indent:35.4pt'><b><u><span lang=TR
style='font-size:10.0pt;line-height:115%;font-family:Tahoma;color:#003399;
mso-ansi-language:TR'><a href="uyku5.jpg">&#350;ekil 5.</a></span></u></b><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> REM uykusu �sawtooth� dalgalar&#305;</span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=TR style='font-size:14.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>UYKU HASTALIKLARI</span></b></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Uykuya ba&#287;l&#305;
hastal&#305;klar eri&#351;kin ya&#351; grubunda s&#305;k g�r�l�r ve ya&#351;la
birlikte artar. Medikal ve psikososyal komorbidite varl&#305;&#287;&#305;nda
prevalans daha da artar. Klinisyenlerin uyku konusunda yeterli bilgi ve
deneyimlerinin olmamas&#305; nedeniyle hastada uyku hastal&#305;klar&#305;
sorgulamas&#305;n&#305;n yap&#305;lmamas&#305; veya hastan&#305;n
yak&#305;nmalar&#305;n&#305;n uykuyla ilgili olabilece&#287;inin
d�&#351;�n�lmemesi i&#351;leri daha karma&#351;&#305;k hale getirmektedir.
Ya&#351;l&#305; ki&#351;ilerde uyku hastal&#305;klar&#305; ile di&#287;er
a&#287;&#305;r medikal problemleri aras&#305;nda g��l� klinik ili&#351;ki
vard&#305;r. Hipertansiyon, depresyon, kardiyovask�ler ve serebrovask�ler
hastal&#305;klarla uyku hastal&#305;klar&#305;n&#305;n �ok yak&#305;n ilgisi
vard&#305;r. Primer uyku hastal&#305;klar&#305;na g�re bir ba&#351;ka
hastal&#305;&#287;a ba&#287;l&#305; ortaya �&#305;kan sekonder uyku
hastal&#305;klar&#305;yla daha s&#305;k kar&#351;&#305;la&#351;maktay&#305;z.
Uyku hastal&#305;klar&#305; �nemli bir halk sa&#287;l&#305;&#287;&#305;
sorunudur. ��nk� toplumun en az %10�u uyku ile ilgili problem
ya&#351;amaktad&#305;r. Tan&#305;mlanm&#305;&#351; 100�den fazla uyku
hastal&#305;&#287;&#305; vard&#305;r. Klinik pratikte en s&#305;k
kar&#351;&#305;la&#351;&#305;lanlar insomni, g�n i�i a&#351;&#305;r&#305;
uyuma, uyku apnesi, parasomni ve huzursuz bacak sendromudur. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&#304;NSOMN&#304;</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Son 50 y&#305;lda yap&#305;lan
ara&#351;t&#305;rmalarda toplum i�inde prevalans&#305; en y�ksek olan ve �ok
ciddi ekonomik kayba yol a�an hastal&#305;klardan biridir. Uykuya dalmakta,
uykuyu devam ettirmede zorluk ve/veya istenilenden �nce uyanma durumudur.
Uykusuzlu&#287;un do&#287;as&#305;, �nemi ve �ok say&#305;da nedenin
olmas&#305; ve klinisyenlerce yeterli derecede bilinip sorgulanmamas&#305;
durumu zorla&#351;t&#305;rmaktad&#305;r. Toplumda hastalar&#305;n �ok b�y�k bir
k&#305;sm&#305; tan&#305; konmaks&#305;z&#305;n �aresiz halde
kalmaktad&#305;rlar. Uyku, a&#351;&#305;r&#305; endi&#351;e,
a&#351;&#305;r&#305; anksiyete ve depresif duygudurumu gibi bir�ok internal
fakt�re hassast&#305;r. D&#305;&#351; fakt�rler a�&#305;s&#305;ndan bakarsak,
ge�ici stresler, �nemli ya&#351;am olaylar&#305; (hastal&#305;k, kaza, evlenme,
bo&#351;anma, e&#287;itim, meslek edinme, gelir d�zeyinde azalma, i&#351;siz
kalma), a&#351;&#305;r&#305; g�r�lt�, y�ksek veya d�&#351;�k &#305;s&#305;lar,
rahats&#305;z yatak, y�ksek rak&#305;m, �jet lag�, ila� b&#305;rakma,
al&#305;&#351;&#305;k olunmayan ko&#351;ullarda uyuma en �ok g�r�len
nedenlerdir. Kad&#305;nlarda erkeklere oranla daha fazla insomni
yak&#305;nmalar&#305; belirlenmi&#351;tir. &#304;nsomni primer ve sekonder
olarak ikiye ay&#305;r&#305;l&#305;r. <i>Primer insomni</i>, medikal veya
psikiyatrik bozukluklar olmaks&#305;z&#305;n ortaya �&#305;kar. <i>Sekonder
insomni</i>; s�regiden psi&#351;ik stres, medikal veya psikiyatrik bir hastal&#305;k
veya ba&#351;ka bir uyku hastal&#305;&#287;&#305;n&#305;n (uykuda periyodik
ekstremite hareket bozuklu&#287;u, vardiyal&#305; i&#351; uyku bozuklu&#287;u,
�jetlag�, obstr�ktif uyku apne sendromu) bir komponenti olarak g�r�l�r. K�t�
uyku hijyeni veya zarar verici �evresel ortamlar sonucu da olabilmektedir.
Keyif amac&#305;yla al&#305;nan ila�lar, alkol ve kafein de rol oynayabilir.
&nbsp;&nbsp;Etyolojik fakt�rlere y�nelik olarak kronik uyuma zorlu&#287;u,
sirkadyen ritm bozukluklar&#305;, psikiyatrik hastal&#305;klar, farmakolojik
ila�lar, medikal hastal&#305;klar, uykuya ba&#287;l&#305; fizyolojik
bozukluklar, negatif &#351;artlanma etkileri say&#305;labilir. Uyuyamama sorunu
olan bir ki&#351;ide insomni tedavisi tek de&#287;ildir. &#304;nsomni alt
tipinin belirlenmesi tedavinin se�imini kolayla&#351;t&#305;r&#305;r. �ok
s&#305;k g�r�len insomni, 30�dan fazla tan&#305; alt tipi olan klinik bir semptomdur.
Yeti&#351;kinlerin yakla&#351;&#305;k 1/3��nde y&#305;l i�inde bir veya daha
fazla d�nem uykusuzluk problemi belirlenmi&#351;tir.&nbsp; Bir
�al&#305;&#351;mada rastgele se�ilen eri&#351;kinlerin&nbsp; %95�i
ya&#351;amlar&#305;n&#305;n bir d�neminde insomni
tan&#305;mlam&#305;&#351;lard&#305;r. Toplumda %10-15 ki&#351;ide mevcuttur. Ya&#351;la
birlikte art&#305;&#351; g�sterir. Ya&#351;l&#305;larda prevalans
yakla&#351;&#305;k %25 ve daha fazlad&#305;r. Yap&#305;lan bir
�al&#305;&#351;mada 55 ya&#351; �zeri eri&#351;kinlerin %67�sinin haftan&#305;n
en az birka� g�n� uyku problemi ya&#351;ad&#305;klar&#305; belirlenmi&#351;tir.
&nbsp;Di&#287;er bir meta analiz �al&#305;&#351;malar&#305;nda kronik insomni
prevalans&#305; yakla&#351;&#305;k %4.4-48 olarak izlenmi&#351;tir. Tedavisiz
insomni ciddi sosyal, mesleki, kognitif fonksiyon bozuklu&#287;una neden olur
ve maj�r depresyon i�in artm&#305;&#351; risk ile ili&#351;kilidir. ABD�de 1995
y&#305;l&#305;nda insomni tedavisi i�in yakla&#351;&#305;k harcama 13,926,110,000
$ olarak bildirilmi&#351;tir.</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>�yk� �ok �nemli bulgular&#305; ortaya
�&#305;kar&#305;r. Ayr&#305;nt&#305;l&#305; uyku �yk�s� sorgulama formunu hasta
g�r�&#351;me �ncesinde doldurur (<b>Tablo 1</b>). G�r�&#351;me
s&#305;ras&#305;nda ise bu formun i�eri&#287;i ayr&#305;nt&#305;l&#305;
&#351;ekilde de&#287;erlendirilir.&nbsp; Yatak partnerinin hastan&#305;n uykusu
ile ilgili verece&#287;i bilgiler tan&#305; konmas&#305;na �ok
yard&#305;mc&#305; olacakt&#305;r. &#304;nsomninin paterni, s�resi, daha �nce
veya halen kullan&#305;lan ila�lar, madde ve alkol kullan&#305;m&#305;, medikal
veya psikiyatrik hastal&#305;klar ve di&#287;er uyku bozukluklar&#305;n&#305;n
bulgu ve belirtileri ayr&#305;nt&#305;l&#305; bir &#351;ekilde
sorgulanmal&#305;d&#305;r. Uyku sorununu ortaya �&#305;karacak �zge�mi&#351;
de&#287;erlendirmesinde t�m sistemler ayr&#305;nt&#305;l&#305; olarak g�zden
ge�irilir. Romatolojik hastal&#305;klar (artrit, fibromiyalji), akci&#287;er
hastal&#305;klar&#305; (ast&#305;m, kronik obstr�ktif akci&#287;er
hastal&#305;&#287;&#305;), kardiyak hastal&#305;klar, gastrointestinal
hastal&#305;klar (refl�, peptik �lser), n�rolojik hastal&#305;klar (n�bet ),
endokrin hastal&#305;klar (hipertiroidizm) en s&#305;k uyku problemi ile
kar&#351;&#305;la&#351;&#305;lan durumlard&#305;r. Kronik
a&#287;r&#305;n&#305;n varl&#305;&#287;&#305;, menopozal d�nemdeki kad&#305;n,
prostat hastal&#305;&#287;&#305; olan erkek hastada uyku sorununun olas&#305;
nedenleridir.<b><span style='color:white'> </span></b>Etyolojik fakt�re g�re
insomni tan&#305;s&#305; <b>Tablo 2</b>�de �zetlenmi&#351;tir. &nbsp;Bir�ok
ila� insomniye yol a�ar (stim�lanlar, steroidler, antihipertansifler,
antidepresanlar) (<b>Tablo 3</b>). Baz&#305; antidepresanlar insomninin
yan&#305;s&#305;ra uykuda periyodik ekstremite hareket bozuklu&#287;unu da
artt&#305;rabilir. Bu durumda sekonder insomniye yol a�ar. Sedatif veya
hipnotik ila�lar&#305;n �rebound� insomniye neden olabilece&#287;i
anlat&#305;lmal&#305; ve bu ila�lar&#305;n kesilmesi konusunda hasta
bilin�lendirilmelidir. &nbsp;Bir�ok hasta kulaktan dolma y�ntemlerle uyku
sa&#287;lamaya �al&#305;&#351;&#305;r (melatonin, alkol ve antihistaminikler).
Yasal olmayan madde kullan&#305;m&#305; �zellikle sorgulanmal&#305;d&#305;r.
Tam bir n�rolojik muayene ve psikiyatri kons�ltasyonu
yap&#305;lmal&#305;d&#305;r. Depresyon ve anksiyete semptomlar&#305;n&#305;n
olmas&#305; �nemlidir. Hastan&#305;n kendisinin alg&#305;lad&#305;&#287;&#305;
stres seviyesi sorgulan&#305;r. K&#305;sa psikolojik de&#287;erlendirmenin
yan&#305;nda baz&#305; hastalarda problemi ortaya �&#305;karmak ve ileri
de&#287;erlendirme i�in psikometrik testler yap&#305;l&#305;r ve psikiyatrik
g�r�&#351;melere devam edilebilir. Hastalardan uyku g�nl�&#287;�n�
doldurmas&#305; istenir. Bu, g�n i�i k&#305;sa g�nd�z uykular&#305; veya
de&#287;i&#351;ken yatma/uyanma saatlerinin tespiti i�in �nemlidir. Tan&#305;
konduktan sonra davran&#305;&#351;sal ve/veya uygun farmakolojik tedavi verilir.
Yan&#305;t vermezse primer uyku hastal&#305;&#287;&#305;n&#305;
d&#305;&#351;lamak ve uyku kesintilerini g�stermek amac&#305;yla polisomnografi
(PSG) yap&#305;lmal&#305;d&#305;r. �yk�de ve fizik muayenede medikal veya
psikiyatrik hastal&#305;&#287;&#305; d�&#351;�nd�recek bulgular varsa ileri
tetkikler yap&#305;lmal&#305;d&#305;r. </span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp; </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-bottom:none;background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>Tablo 1. </span></b><span
  lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;
  color:white;mso-ansi-language:TR'>&#304;nsomnide klinik g�r�&#351;me&nbsp; </span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uyku �yk�s� ve de&#287;erlendirme</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Yak&#305;nman&#305;n patern,
  ba&#351;lang&#305;�, �yk�, gidi&#351;, s�resi, &#351;iddeti</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Predispozan ve tetikleyici fakt�rler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>&#304;nsomniyi artt&#305;ran veya uykuyu
  d�zelten fakt�rler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Etyolojik fakt�r</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Uyku-uyan&#305;kl&#305;k paterni</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>G�n i�i semptom varl&#305;&#287;&#305; (uyku
  hali, a&#351;&#305;r&#305; uyan&#305;kl&#305;k)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Deneyimlenen etki (sonu�lar&#305;,
  bozulmas&#305;)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:9'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Yatak odas&#305; ortam&#305;na uyumsuzluk</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:10'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>&nbsp;Yatma zaman&#305; fizyolojik veya kognitif
  uyanma</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:11'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Ba&#351;ka uyku bozukluklar&#305;na ait
  semptomlar</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:12'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Uyku ortam&#305; (yatma zaman&#305; rutinleri,
  uykuyla uyumsuz davran&#305;&#351;lar)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:13'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Uyku hijyen prati&#287;i</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:14'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Ya&#351;am &#351;ekli (g�nl�k aktivite, egzersiz
  paterni)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:15'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Tedavi �yk�s� (kulaktan dolma �areler, ba&#351;a
  �&#305;kma y�ntemleri, eski tedavilere cevap)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:16'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Tedavi beklentisi</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:17'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&#304;la� ve madde
  kullan&#305;m&#305;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:18'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Uyku ilac&#305;, ev yap&#305;m&#305; veya
  bitkisel destekler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:19'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Re�ete edilmi&#351; ila�lar</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:20'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Re�etesiz ila�lar (diyet ila�lar&#305;,
  antihistaminikler)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:21'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Alkol, t�t�n, kafein</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:22'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Yasal olmayan maddeler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:23'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>�zge�mi&#351;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:24'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Uyku bozuklu&#287;u ile ili&#351;kili medikal
  t&#305;bbi hastal&#305;k</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:25'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Kronik a&#287;r&#305;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:26'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Menopoz (kad&#305;n)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:27'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Prostat hastal&#305;&#287;&#305; (erkek)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:28'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>&#304;ndikasyon varsa laboratuvar tetkiki</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:29'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Psikiyatrik �yk�</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:30'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Depresyon</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:31'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Anksiyete</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:32'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Di&#287;er mental sa&#287;l&#305;k problemleri</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:33;mso-yfti-lastrow:yes'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Stres d�zeyi</span></b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-bottom:none;background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>Tablo 2. </span></b><span
  lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;
  color:white;mso-ansi-language:TR'>Etyolojik fakt�re g�re insomni
  tan&#305;s&#305;</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>1-Ge�ici veya k&#305;sa s�reli </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>kayg&#305; nedenli uyku bozuklu&#287;u</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>2-Psikofizyolojik ve /veya
  �n&#351;artlanma fakt�rleri </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>psikofizyolojik insomni</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>idyopatik insomni</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>uykuyu hatal&#305; alg&#305;lama bozuklu&#287;u
  sendromu</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>yetersiz uyku hijyeni</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>3-Psikiyatrik bozukluklara
  ba&#287;l&#305; uyku bozukluklar&#305;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:9'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>psikoz ile ili&#351;kili uyku bozuklu&#287;u</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:10'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>duygudurum bozuklu&#287;u ile ili&#351;kili uyku
  bozuklu&#287;u</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:11'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>anksiyete bozuklu&#287;u ile ili&#351;kili uyku
  bozuklu&#287;u</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:12'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>panik bozuklukla ile ili&#351;kili uyku
  bozuklu&#287;u</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:13'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>alkolizm ile ili&#351;kili uyku bozuklu&#287;u</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:14'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>4-Tedaviye, ilaca ve alkole ba&#287;&#305;ml&#305;
  insomni</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:15'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>hipnotik
  ba&#287;&#305;ml&#305;l&#305;&#287;&#305; uyku bozuklu&#287;u</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:16'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>stim�lan
  ba&#287;&#305;ml&#305;l&#305;&#287;&#305; uyku bozuklu&#287;u</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:17'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>alkol ba&#287;&#305;ml&#305;l&#305;&#287;&#305;
  uyku bozuklu&#287;u</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:18'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>5-Sirkadyen ritim bozuklu&#287;u ile
  ili&#351;kili uyku bozuklu&#287;u</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:19'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>gecikmi&#351; uyku faz&#305; sendromu</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:20'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>ilerlemi&#351; uyku faz&#305; sendromu</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:21'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>vardiyal&#305; i&#351; uyku bozuklu&#287;u</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:22'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>d�zenli olmayan uyku-uyan&#305;kl&#305;k paterni</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:23'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>6-Uyku bozukluklar&#305;na
  ba&#287;l&#305; sekonder insomni</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:24'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>uykuda periyodik ekstremite hareket
  bozuklu&#287;u (UPEHB)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:25'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>huzursuz bacak sendromu (HBS)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:26'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>santral uyku apnesi</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:27'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>obstr�ktif uyku apnesi</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:28'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>narkolepsi</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:29'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>7-N�rolojik hastal&#305;klara
  ba&#287;l&#305; insomni</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:30'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>dejeneratif hastal&#305;klar</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:31'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>demans</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:32'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>parkinsonizm</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:33'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>8-Di&#287;er dahili
  hastal&#305;klara ba&#287;l&#305; insomni</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:34'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>fibrozit sendromu</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:35'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>uykuyla ili&#351;kili gastro�zofageal refl�</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:36'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>kronik obstr�ktif akci&#287;er
  hastal&#305;&#287;&#305;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:37'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>9-Durumsal fakt�rlerle ili&#351;kili
  insomni</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:38;mso-yfti-lastrow:yes'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>�evresel nedenli uyku bozuklu&#287;u</span></b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-bottom:none;background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>Tablo 3. </span></b><span
  lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;
  color:white;mso-ansi-language:TR'>&#304;nsomniye yol a�an s&#305;k
  kullan&#305;lan ila�lar</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Antihipertansifler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Klonidin</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Beta blokerler (propranolol, atenolol, pindolol)</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Metildopa</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Rezerpin</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Antikolinerjikler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>&#304;pratropium bromid</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Santral sinir sistemi
  stimulanlar&#305;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Metilfenidat</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Hormonlar</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Oral kontraseptifler</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Tiroid preparatlar&#305;</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Kortizon</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Progesteron</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:9'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Sempatomimetik aminler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:10'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Bronkodilat�r &nbsp;(terbutalin, albuterol,
  salmeterol, metaproterenol)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:11'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Ksantin deriveleri (teofilin)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:12'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Dekonjestanlar (fenilpropanolamin, ps�doefedrin)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:13'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Antineoplastikler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:14'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Medroksiprogesteron</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>L�prolid asetat</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Goserelin asetat</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Pentostatin</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Donorubisin</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>&#304;nterferon alfa</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:15'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Di&#287;erleri</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:16;mso-yfti-lastrow:yes'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Fenitoin</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Nikotin</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Levodopa</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Kinidin</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Kafein (re�etesiz)&nbsp; (anasin, ekserdin,
  empirin, �ks�r�k/so&#287;uk alg&#305;nl&#305;&#287;&#305; preparatlar&#305;)</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt'><b><span lang=TR
  style='font-size:9.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b><i><span lang=TR style='font-size:12.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></i></b></p>

<p class=MsoNormal><b><i><span lang=TR style='font-size:12.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>&#304;dyopatik &#304;nsomni:</span></i></b><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> Nadir g�r�len ve ya&#351;am boyu s�ren bir insomnidir. Tipik olarak
do&#287;umdan itibaren ba&#351;layaca&#287;&#305; gibi ergenli&#287;in erken
d�neminde de ba&#351;layabilir. Uykunun reg�lasyonunu sa&#287;layan merkezlerde
bir anormallik oldu&#287;u y�n�nde spek�lasyonlar vard&#305;r. Kronik
uykusuzluk; genel iyilik halini, duygudurumu, motivasyonu, vijilansu,
konsantrasyonu ve enerjiyi azalt&#305;r, olumsuz y�nde etkiler, yorgunluk etkileri
g�r�l�r. Hafif ve orta d�zeyde idyopatik insomnide ise yukar&#305;da
say&#305;lan belirtiler normal s&#305;n&#305;rlar i�inde kalabilir. Ancak
a&#287;&#305;r d�zeyde gidi&#351; g�steriyorsa g�n i�i fonksiyonlarda belirgin
bozulma ve a&#287;&#305;r depresif bulgular izlenebilir.&nbsp; Ya&#351;am boyu
bir hastal&#305;k i�in tedavisi zordur.&nbsp; �yk�de s&#305;kl&#305;kla
a&#351;&#305;r&#305; hipnotik ve alkol kullan&#305;m&#305; vard&#305;r.</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><i><span lang=TR style='font-size:12.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>Uykuyu Hatal&#305; Alg&#305;lama
Bozuklu&#287;u:</span></i></b><b><span lang=TR style='font-size:12.0pt;
line-height:115%;font-family:Tahoma;mso-ansi-language:TR'> </span></b><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>S�bjektif olarak insomni tarif eden hastalar&#305;n yap&#305;lan uyku
laboratuar incelemelerinde dikkat �ekici bir �zellik yoktur. Prevalans&#305; bilinmemektedir.
S�bjektif ve objektif belirtilerdeki �eli&#351;kiyi a�&#305;klamak g��t�r.
Muhtemelen uyku s&#305;ras&#305;nda devam eden ya&#351;an&#305;lm&#305;&#351;
etraf alg&#305;s&#305;n&#305;n devam etmesi ve ki&#351;i taraf&#305;ndan bu
s�renin uyan&#305;kl&#305;k olarak alg&#305;lanmas&#305;d&#305;r. Standart uyku
kay&#305;tlar&#305; ve �l��lemeyen kognitif aktivite ki&#351;ideki bu sorunu
g�steremez. Genellikle kabul g�ren a�&#305;klama, ki&#351;inin REM uykusu
s&#305;ras&#305;ndaki r�yalar&#305;n&#305; kendi uyan&#305;kl&#305;k deneyimi
olarak alg&#305;lamas&#305;d&#305;r.</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&#304;nsomni Tedavisi:</span></b><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> Farmakolojik ve farmakolojik olmayan ila� tedavisi &#351;eklindedir.
Farmakolojik olmayan tedavide davran&#305;&#351;sal ve kognitif teknikler
uykunun ba&#351;lat&#305;lmas&#305; ve idame ettirilmesini sa&#287;lar.
Davran&#305;&#351;sal tekniklerden en �ok kullan&#305;lanlar aras&#305;nda
gev&#351;eme teknikleri (<b>Tablo 4</b>), uyaran kontrol� (<b>Tablo 5</b>),
&nbsp;uyku k&#305;s&#305;tlamas&#305; (<b>Tablo 6</b>), biyogeribildirim (<b>Tablo
7</b>) ve uyku hijyen e&#287;itimi (<b>Tablo 8</b>) say&#305;labilir.&nbsp;
Uykuya dalmakta sorun ya&#351;ayan ki&#351;ilerde farmakoterapi kadar etkin
olan uyaran kontrol� ve uyku k&#305;s&#305;tlamas&#305; en iyi tedavi se�imi
olabilir. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-bottom:none;background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>Tablo 4 . </span></b><span
  lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;
  color:white;mso-ansi-language:TR'>Gev&#351;eme teknikleri</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Rehber</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Hastaya s�ylenmesi gereken</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>uzan, g�zlerini kapa, rahatla</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>baz&#305; kas gruplar&#305;n&#305; kasarak
  hissetmeye �al&#305;&#351;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>gerginli&#287;i azalt ve gev&#351;emeye
  �al&#305;&#351;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>farkl&#305; kas gruplar&#305; i�inde ayn&#305;
  gev&#351;emeyi tekrarla</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>K&#305;sa d�nem etkisi</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>hafif gev&#351;eme</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:9'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>gev&#351;eme tekniklerinde ustala&#351;mak i�in
  zamana ihtiya� oldu&#287;u belirtilmeli</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:10'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uzun d�nem etkisi</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:11;mso-yfti-lastrow:yes'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>anksiyeteyi ve/veya uyku zaman&#305; kas
  gerginli&#287;ini azaltma tekniklerini kullanabilir olma</span></b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-bottom:none;background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>Tablo 5. </span></b><span
  lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;
  color:white;mso-ansi-language:TR'>Uyaran kontrol bilgilenmesi&nbsp;&nbsp;
  i�in gerekenler</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Rehber </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><b><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Tahoma;
  mso-ansi-language:TR'>1-</span></b><b><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></b><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>kendinizi uykulu
  hissediyorsan&#305;z, sadece o zaman uyumak i�in uzan&#305;n</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><b><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Tahoma;
  mso-ansi-language:TR'>2-</span></b><b><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></b><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>uyumak d&#305;&#351;&#305;nda
  yata&#287;&#305;n&#305;z&#305; ve yatak odan&#305;z&#305; kullanmay&#305;n</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><b><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Tahoma;
  mso-ansi-language:TR'>3-</span></b><b><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></b><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>yakla&#351;&#305;k 20 dakika i�inde
  uykunuz gelmediyse yataktan kalk&#305;p ba&#351;ka bir odaya gidin. Tekrar
  uykunuz gelirse,&nbsp; gev&#351;eme hareketlerini yapt&#305;ktan sonra
  yata&#287;&#305;n&#305;za gidin</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><b><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Tahoma;
  mso-ansi-language:TR'>4-</span></b><b><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></b><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>uyku hala yok ise veya uykudan
  uyan&#305;rsan&#305;z, 3. maddeyi tekrarlay&#305;n</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><b><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Tahoma;
  mso-ansi-language:TR'>5-</span></b><b><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></b><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>her sabah ayn&#305; saatte �alar
  saat&#305; kurun ve uyudu&#287;unuz s�reyi dikkate almaks&#305;z&#305;n
  ayn&#305; saatte kalk&#305;n</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>K&#305;sa d�nem etkiler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Hasta gecede birka� kez kalkma ihtiyac&#305;
  duyabilir ve uykusu ka�abilir </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:9'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uzun d�nem etkiler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:10;mso-yfti-lastrow:yes'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Hasta uyumsuz uyku
  �a&#287;r&#305;&#351;&#305;mlar&#305;n&#305; de&#287;i&#351;tirecek, uyku
  �a&#287;r&#305;&#351;&#305;mlar&#305; ile h&#305;zl&#305; uykuya dalma
  aras&#305;ndaki ba&#287;&#305; yeniden kuracakt&#305;r</span></b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-bottom:none;background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>Tablo 6 . </span></b><span
  lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;
  color:white;mso-ansi-language:TR'>Uyku k&#305;s&#305;tlamas&#305;</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Rehber </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Hasta iki haftadan uzun bir s�re ile
  g�nl�k uyku patern kay&#305;tlar&#305;n&#305; uyku g�nl�&#287;�ne doldurur</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&#304;ki haftal&#305;k s�rede toplam
  uyku zaman&#305;n&#305;n ortalamas&#305; ba&#351;lang&#305;� olarak
  al&#305;n&#305;r, yataktan kalkma zaman&#305; ve yata&#287;a yatma
  zaman&#305; aras&#305;ndaki s�re hesaplan&#305;r. Toplam uyku zaman&#305;
  dikkate al&#305;nmaks&#305;z&#305;n yatakta minimum kalma zaman&#305; 4.5
  saatin alt&#305;nda olmamal&#305;d&#305;r. Hastalara istenen saatte
  yat&#305;p yatmad&#305;klar&#305;na bakmaks&#305;z&#305;n belirlenen saatte
  kalkmalar&#305; s�ylenmelidir. Belirlenen uyku saatleri
  d&#305;&#351;&#305;nda uzanmaya veya k&#305;sa g�nd�z uykular&#305;na izin
  verilmez. </span></b><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Hasta uyku g�nl�&#287;�ne yatma
  zaman&#305;n&#305; ve tahmini total uyku zaman&#305;n&#305; yazar ve&nbsp; uykunun
  &nbsp;etkinli&#287;i &nbsp;(tahmini toplam uyku zaman&#305;/yatakta kalma
  zaman&#305; y�zde olarak hesaplan&#305;r) her hafta de&#287;erlendirilir.</span></b><span
  lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Ba&#351;lang&#305;�taki
  s&#305;n&#305;rl&#305; uyku s�recinden sonra yatma zaman&#305;n&#305;
  ayarlay&#305;n. Bu d�zenleme a&#351;a&#287;&#305;daki gibi yap&#305;labilir</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Yatma zaman&#305; 3 kritere g�re
  ayarlan&#305;r:</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><b><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Tahoma;
  mso-ansi-language:TR'>1.</span></b><b><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></b><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>ortalama uyku etkinli&#287;i%90 ve
  �st�nde ise (ya&#351;l&#305;larda %85) ki&#351;inin yatakta kalma zaman&#305;
  15 dakika artt&#305;r&#305;l&#305;r, yata&#287;a yatma zaman&#305; erkene
  �ekilir </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><b><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Tahoma;
  mso-ansi-language:TR'>2.</span></b><b><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></b><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>uyku etkinli&#287;i ortalamas&#305;
  %85�den d�&#351;�k ise (ya&#351;l&#305;larda %80) yatakta kalma zaman&#305;
  15 dakika azalt&#305;l&#305;r</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:9'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><b><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Tahoma;
  mso-ansi-language:TR'>3.</span></b><b><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></b><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>uyku etkinli&#287;i %85-90
  aras&#305;nda ise yatakta kalma zaman&#305;nda de&#287;i&#351;iklik
  yap&#305;lmaz. </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:10'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>K&#305;sa d�nem etkiler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:11'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Hafif uykusuzluk, artan yorgunluk, huzursuzluk
  ve uykululuk hali beklenebilir.&nbsp; </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:12'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Hasta yatakta daha fazla zaman ge�irme arzusuna
  direnmekte zorluk �ekebilir.</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:13'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Hasta giderek daha derin ve kesintisiz
  uyuyabilecektir. </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:14'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uzun d�nem etkileri</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:15;mso-yfti-lastrow:yes'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Yatakta kal&#305;nan zaman
  sistematik &#351;ekilde artt&#305;r&#305;ld&#305;k�a hasta sonunda yeterli miktarda
  kaliteli bir uykuya sahip olacakt&#305;r. </span></b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-bottom:none;background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>Tablo 7. </span></b><span
  lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;
  color:white;mso-ansi-language:TR'>�Biyogeribildirim�</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Rehber </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>I&#351;&#305;k, ses vb.
  uyaranlar&#305;ndan uzakla&#351;mak veya uzakla&#351;t&#305;rmak</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>K&#305;sa d�nem etkileri</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Hastalar fizyolojik parametreleri kontrol
  becerisini geli&#351;tirmek i�in bir �ok e&#287;itim seans&#305;na ihtiya�
  duyabilirler.</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uzun d�nem etkileri</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6;mso-yfti-lastrow:yes'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Hasta anksitesini ve/veya kas gerginli&#287;ini
  azaltmay&#305; veya santral uyku mekanizmalar&#305;n&#305;
  artt&#305;rmay&#305; ve daha iyi uyuyabilmeyi �&#287;renecektir</span></b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></p>

<p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-bottom:none;background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>Tablo 8. </span></b><span
  lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;
  color:white;mso-ansi-language:TR'>Uyku Hijyen E&#287;itimi</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>G�n i�i ve ak&#351;am
  al&#305;&#351;kanl&#305;klar&#305;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>G�n�n ilerleyen saatlerinde a&#351;&#305;r&#305;
  kafein t�ketmek</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Sigara i�mek</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Ak&#351;am alkol kullanmak</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>G�n i�inde ve ak&#351;amlar&#305; k&#305;sa
  s�reli uyku uyumak, uyuklamak, uyuyakalmak(s&#305;zmak)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>G�n i�inde gev&#351;eyerek uzanma (rahatlama
  veya gev&#351;eme amac&#305;yla uzanmak)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Ak&#351;am&#305;n ge� saatlerinde spor yapmak</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Uyku korkusu/endi&#351;esi i�inde olmak,
  &nbsp;ak&#351;amlar&#305; uyuyamama endi&#351;esi ya&#351;amak</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:9'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>G�nl�k ko&#351;u&#351;turmay&#305; yeterince
  azaltmamak</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:10'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>&nbsp;Uyku ka�&#305;ran yatma
  haz&#305;rl&#305;klar&#305;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:11'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Uyku �ncesi d�zenli rit�el olmamas&#305;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:12'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Can s&#305;k&#305;c&#305; uyku �ncesi yatak
  konu&#351;malar&#305; </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:13'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Ak&#351;am ge� saatlerde yemek yemek ve
  s&#305;v&#305; almak (s&#305;k idrar �&#305;k&#305;&#351;&#305;na neden
  olabilir)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:14'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>I&#351;&#305;klar&#305; kapamadan �nce
  televizyon seyretmek, kitap okumak veya uyku uyumaya engel olabilecek
  davran&#305;&#351;lar&#305; yapmak </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:15'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Gece
  al&#305;&#351;kanl&#305;klar&#305;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:16'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>D�zensiz uyku ve uyan&#305;kl&#305;k saatleri</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:17'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Yatakta uyumak i�in uzun saatler ge�irmek</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:18'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Televizyon veya radyo a�&#305;k uykuya dalmak</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:19'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>&nbsp;Uyumaya fazla gayret etmek</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:20'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Yatak partnerinin horlamas&#305;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:21'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>&nbsp;Gece boyu s�rekli uykusuz ge�en
  zaman&#305; hesaplamak</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:22'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Uyan&#305;kken yatakta kalmaya devam etmek</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:23'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Sabah
  al&#305;&#351;kanl&#305;klar&#305; </span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:24'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Sabahlar&#305; uyand&#305;ktan sonra yatakta
  kalmak</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:25'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Hafta sonunda ekstra uyumak</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:26'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Yatak odas&#305;nda g�r�lt�, g�ne&#351;
  &#305;&#351;&#305;&#287;&#305; veya evcil hayvanlar&#305;n olmas&#305;</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:27;mso-yfti-lastrow:yes'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>&#304;lerlemi&#351; sirkadyen ritim faz&#305;na
  ba&#287;l&#305; erken sabah uyanmay&#305; kolayla&#351;t&#305;ran sabah g�n
  &#305;&#351;&#305;&#287;&#305;na mazur kalmak</span></b></p>
  </td>
 </tr>
</table>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></p>

<p class=MsoNormal><i><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Farmakolojik tedavi</span></i><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> olarak benzodiazepin, benzodiazepin resept�r agonistleri, sedasyon yapan
antidepresanlar verilir (<b>Tablo 9</b>). G�n i�i anksiyete olmad&#305;k�a
k&#305;sa ve orta etkili ila�lar genellikle tercih edilir. Hastan&#305;n klinik
bulgu ve belirtilerine g�re ila� se�imi yap&#305;l&#305;r. Uykuya dalmakta
yak&#305;nmalar&#305; olan ki&#351;ide �ok k&#305;sa etkili ila� yatmadan hemen
�nce verilir. Depresyon semptomlar&#305; olan hastalarda sedatif etkili
antidepresan se�imi en uygunudur. Uzun etkili ila�lar&#305;n verilmesi
potansiyel tolerans ve ba&#287;&#305;ml&#305;l&#305;k yapt&#305;&#287;&#305;
i�in tercih edilmezler. Benzodiazepinler&nbsp; (BZD), GABA �zerinden
benzodiazepin resept�rlerine (BZD R) ba&#287;lanarak etki ederler. GABA
resept�r kompleksine ba&#287;land&#305;&#287;&#305;nda klor
kanallar&#305;n&#305; a�arak n�ronlar&#305; hiperpolarize eder. GABA<sub>A</sub>�n&#305;n
5 alt tipi vard&#305;r. Alfa 1 alt tipi BZD R1�dir. PSG ile BZD�lerin uyku
latans&#305;n&#305; k&#305;saltt&#305;&#287;&#305; g�sterilmi&#351;tir. Toplam
uyku s�resini uzat&#305;r ancak hem NREM evre 3 ve 4 hem de REM uykusunu
k&#305;salt&#305;r. Uyku i&#287;ciklerini artt&#305;rabilir. Geleneksel BZD�ler
etki s�relerine g�re ayr&#305;l&#305;r. Uzun etkili olanlar uyanma s�resini
geciktirir. K&#305;sa etkililer ise rebound insomni yaparlar. BZD olmayan BZD R
agonistleri (zaleplon, zolpidem) k&#305;sa etkili olmalar&#305;na
kar&#351;&#305;n rebound insomni yapmazlar. BZD R agonistleri fiziksel
ba&#287;&#305;ml&#305;l&#305;k yapma olas&#305;l&#305;&#287;&#305;
olmas&#305;na kar&#351;&#305;n insomni &#351;ikayeti olanlar&#305;n �nceden
ila� ba&#287;&#305;ml&#305;l&#305;&#287;&#305; yoksa pek g�r�lmez. Ancak
fiziksel tolerans ve etkinlik kayb&#305; g�r�l�r. Hipnotik
ba&#287;&#305;ml&#305;s&#305; insomnili hastalar �ok �nemli bir problem olu&#351;turur.
B�yle bir durumda t�m hipnotikler yava&#351; yava&#351; azalt&#305;l&#305;p
kesilir. Davran&#305;&#351; tedavisi tek ba&#351;&#305;na uygulan&#305;r.
Hastalar ilac&#305;n faydal&#305; olmad&#305;&#287;&#305;n&#305; (tolerans)
s�ylemelerine kar&#351;&#305;n ila� kesildi&#287;inde insomnilerinin
k�t�le&#351;ti&#287;ini belirtirler. Di&#287;er grup ila� ise sedasyon yapan
antidepresanlard&#305;r. Bunlar aras&#305;nda Doksepin, amitriptilin,
trimipramin, trazodon, nefzadon ve mirtazapin say&#305;labilir. Trazodon
serotonin tip 2 resept�r antagonisti ve zay&#305;f serotonin gerial&#305;m
inhibit�r�d�r. Trisiklik ila�lar gibi antikolinerjik ve kardiyotoksik yan
etkisi yoktur. Yan etki olarak postural hipotansiyon, priapism ve sabah
sedasyonu olabilir. Mirtazapin yan etki olarak kilo al&#305;m&#305; yapabilir.
Antiepileptikler (gabapentin, tiagabin) ve antipsikotik (quetiapin) hipnotik
olarak kullan&#305;l&#305;r. Efektif antidepresanlar ( selektif serotonin
gerial&#305;m inhibit�rleri, venlafaksin, bupropion) uykusuzlu&#287;u
artt&#305;rabilirler. Uyku problemi devam etti&#287;i takdirde sedasyon yapan
antidepresanlara ge�melidir. Davran&#305;&#351; tedavisi ila� tedavisi kadar
�nemlidir.&nbsp; Davran&#305;&#351; ve psikofarmakolojik tedavilerle insomnide
iyi yan&#305;t al&#305;n&#305;rken bu y�ntemleri kullanan hasta
say&#305;s&#305; �ok s&#305;n&#305;rl&#305; kalmaktad&#305;r.&nbsp;
&#304;nsomni toplumun 1/3��n� etkileyen �nemli bir halk
sa&#287;l&#305;&#287;&#305; sorunudur. �ok say&#305;da ki&#351;iyi etkileyen
insomni i�in toplum e&#287;itiminin verilmesi gereklidir. </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

</div>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=623
 style='width:467.25pt;border-collapse:collapse;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0'>
  <td width=300 colspan=2 valign=top style='width:225.15pt;border:solid #78C0D4 1.0pt;
  border-right:none;background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>Tablo 9. </span></b><span
  lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;
  color:white;mso-ansi-language:TR'>&#304;nsomninin farmakolojik ila� tedavisi</span><span
  lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>
  </td>
  <td width=16 colspan=2 valign=top style='width:11.8pt;border-top:solid #78C0D4 1.0pt;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>&nbsp;</span></b><span
  lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:solid #78C0D4 1.0pt;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>&nbsp;</span></b><span
  lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:solid #78C0D4 1.0pt;
  border-left:none;background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>&nbsp;</span></b><span
  lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>S&#305;n&#305;f</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&#304;la�</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Yar&#305;lanma zaman&#305;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Doz (mg)</span></b></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Benzodiazepin</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Alprazolam</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Orta</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>0.25-2</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>klordiazepoksit</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uzun</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>10-25</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Klonazepam</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uzun</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>0.25-2</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Klorazepat</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uzun</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>7.5-15</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Diazepam</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uzun</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>2-10</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Estazolam</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Orta</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>1-2</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Flurazepam</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uzun</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>15-30</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:9'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Midazolam</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>K&#305;sa</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>7.5-15</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:10'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Lorazepam</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Orta</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>0.5-2</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:11'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Oksazepam</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Orta</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>15-30</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:12'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Temazepam</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Orta</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>15-30</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:13'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Triazolam</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>K&#305;sa</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>0.125-0.25</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:14'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>BZDOBZDRA</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Zaleplon</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>K&#305;sa</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>10-20</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:15'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Zolpidem</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>K&#305;sa</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>5-10</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:16'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>TSA</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Amitriptilin</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uzun</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>10-100</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:17'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Doksepin</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>K&#305;sa</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>10-100</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:18'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&#304;mipramin</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Orta</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>10-100</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:19'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Nortriptilin</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uzun</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>10-100</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:20'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Triazolopridin</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Trazodon</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Orta</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>25-100</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:21'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Antiepileptik </span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Gabapentin</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>k&#305;sa-orta</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>100-600</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:22'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Tiagabin</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Orta</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>4-32</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:23'>
  <td width=154 valign=top style='width:115.15pt;border-top:none;border-left:
  solid #78C0D4 1.0pt;border-bottom:solid #78C0D4 1.0pt;border-right:none;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Dopamin antagonisti</span></b></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Quetiapin</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border:none;
  border-bottom:solid #78C0D4 1.0pt;background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>Uzun</span></p>
  </td>
  <td width=154 colspan=2 valign=top style='width:115.15pt;border-top:none;
  border-left:none;border-bottom:solid #78C0D4 1.0pt;border-right:solid #78C0D4 1.0pt;
  background:#D2EAF1;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>25-100</span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal>&nbsp;</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:24;mso-yfti-lastrow:yes'>
  <td width=154 style='width:115.5pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:12.0pt;font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=147 style='width:110.25pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:12.0pt;font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:12.0pt;font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:12.0pt;font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=145 style='width:108.75pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:12.0pt;font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:12.0pt;font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=145 style='width:108.75pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:12.0pt;font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=10 style='width:7.2pt;padding:0cm 0cm 0cm 0cm'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:12.0pt;font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
</table>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>BZDOBZDRA: benzdiazepin olmayan
benzodiazepin resept�r agonisiti</span></p>

<p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>TSA: trisiklik antidepresan</span></p>

</div>

<p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>UYKUDA SOLUNUM ZORLU&#286;U</span></b><b><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'> </span></b></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>�ok �nemli bir sa&#287;l&#305;k
problemi olmas&#305;na kar&#351;&#305;n tan&#305; konamamas&#305; ve tan&#305;
gecikmeleri bu hastal&#305;&#287;&#305;n komplikasyon ve prognozunu k�t�
etkilemektedir. En �ok obstr�ktif ve santral uyku apnesi ve Cheyne-Stokes
solunumu g�r�l�r. &nbsp;Bir�ok n�rolojik hastal&#305;kta uykuda ortaya
�&#305;kan bu solunum zorluklar&#305;n&#305;n hem obstr�ktif hem de santral
tipte olabilece&#287;i unutulmamal&#305;d&#305;r. Semptomlar detayl&#305;
sorgulanmal&#305;d&#305;r. &#350;�pheli bir durum varsa kesinlikle
polisomnografi (PSG) ile monitorizasyon yap&#305;lmal&#305;d&#305;r.
Ay&#305;r&#305;c&#305; tan&#305; ku&#351;kusu kalmamal&#305;d&#305;r. Uykuda
solunum zorlu&#287;unun anla&#351;&#305;labilmesi i�in baz&#305;
tan&#305;mlar&#305;n yap&#305;lmas&#305; gerekmektedir. <i>Apne</i> en az 10
saniye s�reyle solunumun durmas&#305;d&#305;r. <i>Hipopne</i> ise
torakoabdominal hareketin en az %30 azalmas&#305; veya en az %4 oksijen
desat�rasyonunun olmas&#305;d&#305;r. T�m gece uykusundaki apne ve hipopnelerin
bir indeks (<i>solunum bozuklu&#287;u indeksi, SB&#304;</i>) ile hesaplanmas&#305;ndan
sonra uyku apne sendromunun &#351;iddeti tan&#305;mlanm&#305;&#351; olur. Hafif
uyku apnesi SB&#304; &lt;15, orta derecede uyku apnesi SB&#304; 15-30,
a&#287;&#305;r uyku apnesi SB&#304; &gt;30 olarak de&#287;erlendirilir.</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><i><span lang=TR style='font-size:12.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>Obstr�ktif Uyku Apne Sendromu</span></i></b><b><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> </span></b><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>(OUAS): Genel pop�lasyonda
prevalans&#305; �ok y�ksektir (kad&#305;nlarda %2, erkeklerde %4).&nbsp; Irksal
olarak,&nbsp; obeziteye bak&#305;lmaks&#305;z&#305;n,&nbsp; zencilerde s&#305;k
oldu&#287;u belirlenmi&#351;tir. Yakla&#351;&#305;k diyabet veya ast&#305;m
bron&#351;iyale kadar s&#305;kt&#305;r.&nbsp; En s&#305;k eri&#351;kinlerde,
erkeklerde, horlayan ki&#351;ilerde, postmenopozal d�nemdeki kad&#305;nlarda ve
obez ki&#351;ilerde g�r�l�r. Bunun d&#305;&#351;&#305;nda hipotiroidizm,
akromegali, alkol t�ketimi ve nazal konjesyonu olanlarda da izlenmektedir.
�ocuk, gen� kad&#305;n veya astenik ki&#351;ilerde de g�r�lebilir. OUAS i�in en
s&#305;k g�r�len iki klinik belirti y�ksek sesle horlamak ve g�n i�i
a&#351;&#305;r&#305; uyumad&#305;r.&nbsp; Yatak partnerinin verece&#287;i �yk�
�ok �nemlidir. Y�ksek sesle horlaman&#305;n ard&#305;ndan 15-30 saniye s�ren
apne (en fazla 60 saniye olur) ve apneyi izleyen d�nemde nefes
a�l&#305;&#287;&#305; ile uyanma �yk�s� tan&#305;y&#305; koymak i�in �ok
yard&#305;mc&#305; olur. Gecede bazen 300�den fazla uyanma g�r�l�r. Bu
uyanmalar gece uykusunun devaml&#305;l&#305;&#287;&#305;n&#305; bozar, PSG�de
nadiren NREM yava&#351; uykusu (evre 3-4) ile REM uykusu izlenebilir. Sabah
dinlenmi&#351; olarak kalkmazlar. Bu durumda uyku eksikli&#287;ini tamamlamak
i�in g�n i�i a&#351;&#305;r&#305; uyuma ataklar&#305; ba&#351;lar. En �ok
uyuklama yemek sonras&#305;, televizyon seyrederken, yolculuk yaparken,
ders/konferans dinlerken olur. Bazen yemek yerken, konu&#351;urken ve hatta
araba kullan&#305;rken bile ki&#351;i uykuya yenik d�&#351;ebilir. &nbsp;Dikkat,
konsantrasyon, bellek ve muhakeme ve istenen i&#351;lerin
yap&#305;lmas&#305;ndaki performansta bozulmalar ba&#351;lar. Hastalar&#305;n
%50�si sabah veya ak&#351;am k�nt ba&#351; a&#287;r&#305;s&#305;ndan
yak&#305;n&#305;rlar. Azalm&#305;&#351; libido veya impotans gibi seks�el fonksiyon
bozukluklar&#305;ndan &#351;ikayet�i olabilirler. &nbsp;OUAS�l&#305;
hastalar&#305;n %80�de hipertansiyon vard&#305;r. Di&#287;er deyi&#351;le
primer hipertansiyonu olanlar&#305;n 1/3��nde OUAS vard&#305;r. Apne
s&#305;ras&#305;nda ve sonras&#305;nda akut olarak kan bas&#305;nc&#305;
y�kselir, bu muhtemelen akut hipoksi ve artm&#305;&#351; sempatik aktivitenin
yans&#305;mas&#305;d&#305;r. &#304;drar norepinefrin ve normetanefrin d�zeyleri
hem uykuda hem de uyan&#305;kl&#305;kta y�ksek bulunmaktad&#305;r. Nokt�rnal
akut y�kselen kan bas&#305;nc&#305; y&#305;llar i�inde tedavi edilmezse b�y�k
olas&#305;l&#305;kla renin-anjiotensin sisteminin de etkilenmesi ile kal&#305;c&#305;
hale gelmektedir. OUAS�&#305;n kardiyovask�ler hastal&#305;klarla da
ili&#351;kisi de vard&#305;r. Kardiyak aritmi, iskemik kalp
hastal&#305;&#287;&#305; ve miyokard infarkt&#305; OUAS�l&#305; hastalarda
s&#305;k g�r�lmektedir. Uykudaki apnenin a&#287;&#305;rl&#305;k derecesi ile
kardiyovask�ler hastal&#305;klar aras&#305;nda korelasyon vard&#305;r. Horlayan
bir ki&#351;ide miyokard infarkt&#305; ge�irme riskinin 2-4 kat
artt&#305;&#287;&#305; g�sterilmi&#351;tir. �ocuklarda g�n i�i
a&#351;&#305;r&#305; uyuman&#305;n d&#305;&#351;&#305;nda geli&#351;im
gecikmesi, okul ba&#351;ar&#305;s&#305;nda d�&#351;�kl�k ve iritabilite
g�r�l�r. Bazen yanl&#305;&#351;l&#305;kla dikkat eksikli&#287;i ve
hiperaktivite bozuklu&#287;u tan&#305;s&#305; konabilmektedir. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Uykuda boyun ve g�&#287;�s�n �st
b�lgesinde a&#351;&#305;r&#305; terleme oldu&#287;unu belirtirler. Nefes alma
�abas&#305;na ba&#287;l&#305; d�n�p durma ve debelenme olur. �st solunum
yolunun obstr�ksiyonuna ba&#287;l&#305; negatif intratorasik bas&#305;nca ba&#287;l&#305;
sekonder ven�z d�n�&#351;te artma ve sonu�ta pulmoner damarlarda g�llenme olur.
Bunun klinik g�stergesi de dispnedir. Nokt�ri hastalar&#305;n %28�inde g�r�l�r.
�zafageal refl�, a&#287;&#305;z kurulu&#287;u ve a&#287;&#305;zdan salya
akmas&#305; da g�r�len di&#287;er bulgulard&#305;r.&nbsp; Fizik muayenede �o&#287;unlu&#287;un
obez oldu&#287;unu s�ylemek yanl&#305;&#351; olmaz. &nbsp;V�cut kitle indeksi
&gt;28kg/m<sup>2 </sup>bulunur. &nbsp;Boyun �evresi &gt;40 cm, nazal konka
hipertrofisi, septal deviyasyon, y�ksek yerle&#351;imli ve dar sert
damak,&nbsp; uzun d�&#351;�k yerle&#351;imli uvula ve yumu&#351;ak damak,
geni&#351;lemi&#351; ve belirginlemi&#351; tonsiller ve adenoidlerle
kalabal&#305;k hale gelmi&#351; orofarenks,&nbsp; makroglossi, dar maksilla ve
/veya mandibula, &nbsp;di&#351;lerin malokl�zyonunun olmas&#305; �nemlidir. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Bu �yk� ile gelen hastaya bir gecelik
PSG ve onu takibeden sabahta multipl uyku latans testi istenmelidir.
&nbsp;OUAS�l&#305; hastan&#305;n PSG �rne&#287;i <b>&#350;ekil 6</b>�da g�sterilmi&#351;tir.</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-indent:35.4pt'><b><u><span lang=TR
style='font-size:10.0pt;line-height:115%;font-family:Tahoma;color:#003399;
mso-ansi-language:TR'><a href="uyku6.jpg">&#350;ekil 6.</a></span></u></b><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> Obstr�ktif uyku apnesi: nazo-oral havayolunun ak&#305;&#351;&#305;n&#305;n
durmas&#305; (Kaynak 3�ten)</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></i><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Tedavi:</span></i><span lang=TR
style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> Cerrahi ve cerrahi olmayan tedavi &#351;eklinde ikiye ay&#305;rmak uygun
olur. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Cerrahi olmayan tedavi:</span><span
lang=FI style='mso-ansi-language:FI'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:37.85pt;text-indent:-18.0pt'><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>1.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>Ki&#351;inin kilo vermesi</span><span lang=FI style='mso-ansi-language:
FI'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:37.85pt;text-indent:-18.0pt'><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>2.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;Nikotin, benzodiazepin ve alkol kullanmamal&#305;</span><span
lang=FI style='mso-ansi-language:FI'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:37.85pt;text-indent:-18.0pt'><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>3.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;Narkotik, barbit�rat, narkotikler al&#305;nmamal&#305;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:37.85pt;text-indent:-18.0pt'><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>4.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>S&#305;rt�st� yatmamal&#305;</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:37.85pt;text-indent:-18.0pt'><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>5.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>Komorbid hastal&#305;klar tedavi edilmeli </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:37.85pt;text-indent:-18.0pt'><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>6.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>Oksijen (Apne s�resini k&#305;salt&#305;r, oksihemoglobin sat�rasyonu yeterli
d�zeye gelir, bradikardi ortadan kalkar. Ancak apne frekans&#305;n&#305;
azaltmaz, g�n i�i uykuya etkisi yoktur. Asemptomatik veya minimal OUAS�l&#305;
hastalarda kullan&#305;labilir. )</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:37.85pt;text-indent:-18.0pt'><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>7.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>Psikotropik ila�lar (anksiyolitik, hipnotik), trisiklik antidepresan
protriptilin REM uykusunun s�resini azaltarak ve �st solunum yolu
kaslar&#305;n&#305;n tonusunu artt&#305;rarak OUAS bulgular&#305;n&#305;
azaltabilir. Apneler hipopne olarak g�r�lmeye ba&#351;lar. Otonomik ve kardiyak
bozulmalar geriye d�nebilir. Serotonin gerial&#305;m inhibit�r� de etkili
olabilir.</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:37.85pt;text-indent:-18.0pt'><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>8.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>Devaml&#305; nazal positif havayolu bas&#305;nc&#305; (<i>CPAP</i>: continuous
positive airway pressure)</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:37.85pt;text-indent:-18.0pt'><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>9.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>CPAP almas&#305;na kar&#351;&#305;n halen g�n i�i a&#351;&#305;r&#305;
uyuma varsa Modafinil 200-400mg/g�n verilebilir</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>CPAP, OUAS�l&#305; hastalar&#305;n
b�y�k bir k&#305;sm&#305;nda �st solunum yolunun kollaps&#305;n&#305; �nlemek
i�in kullan&#305;lan solunum cihaz&#305;d&#305;r. �st solunum yolunun kas
tonusunu azalt&#305;r, fonksiyonel rezid�el kapasiteyi artt&#305;r&#305;r. Uyku
s&#305;ras&#305;nda devaml&#305; pozitif havayolu bas&#305;nc&#305; yava&#351;
olarak y�kselir, obstr�ksiyon ortadan kalk&#305;nca horlama da biter. Orta ve
a&#287;&#305;r OUAS�l&#305; olgular ile santral apnesi olan hastalarda standart
tedavi y�ntemidir. Nadir yan etkileri d&#305;&#351;&#305;nda CPAP�a
kar&#351;&#305; tedavi uyumsuzlu&#287;u %40-80 oran&#305;nda g�r�lebilir.
Destek ve e&#287;itim ile bu sorun da a&#351;&#305;labilir. Oksijen sat�rasyonu
%90�&#305;n �zerinde idame etmeye ba&#351;lar.&nbsp; &nbsp;�Bilevel� PAP;
CPAP�&#305; tolere edemeyenlere ve OUAS ile beraber alveoler hipoventilasyona
yol a�an hastal&#305;klar&#305;n varl&#305;&#287;&#305;nda endikedir. �zellikle
n�rom�sk�ler hastal&#305;klar&#305;nda efektiftir. </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Yap&#305;lan �al&#305;&#351;malarda,
solunum bozuklu&#287;u indeksi 5-30 olan ve g�n i�i a&#351;&#305;r&#305;
uyumas&#305;, kognisyon veya duygudurum bozuklu&#287;u, insomnisi, tan&#305;
konmu&#351; kardiyovask�ler hastal&#305;&#287;&#305; (hipertansiyon ve iskemik
kalp hastal&#305;&#287;&#305;) bulunan veya inme ge�irmi&#351; olan
hastalar&#305;n CPAP tedavisinden yararland&#305;&#287;&#305;
g�sterilmi&#351;tir. &nbsp;Kardiyovask�ler hastal&#305;k tan&#305;s&#305;
olmayan ve hafif OUAS�u olanlarda CPAP endikasyonu bulunmamaktad&#305;r.
Efektif CPAP tedavisi nokt�rnal solunum bozuklu&#287;unu, oksijenizasyonu, uyku
d�zenini, g�n i�i uyumay&#305; ve n�rokognitif performans&#305; d�zeltecektir.</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Cerrahi tedavi �st solunum yolunda
obstr�ksiyona yol a�an �zel durumlara kar&#351;&#305; uygulan&#305;r. Bu
obstr�ksiyonlar ��e ayr&#305;larak Fujita tip I-damak ile ilgili
obstr�ksiyonlar, Fujita tip II-hem dil hem damak ile ilgili obstr�ksiyonlarve
Fujita tip III- dil ile ilgili obstr�ksiyonlar &#351;eklinde
s&#305;n&#305;fland&#305;r&#305;l&#305;r. Farkl&#305; etyolojilere y�nelik
farkl&#305; operasyon yakla&#351;&#305;mlar&#305; vard&#305;r. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><i><span lang=TR style='font-size:12.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>Santral Uyku Apnesi:</span></i></b><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> Uyku ba&#351;lang&#305;c&#305;nda normal varyant olarak kabul edilir.
Benzer olarak y�ksek rak&#305;ml&#305; yerlerde de santral apne
g�r�lebilir.&nbsp; Karbondioksitin y�kselmesine de&#287;i&#351;ken yan&#305;t
g�steren idyopatik santral uyku apnesi olabilmekle birlikte en �ok
kar&#351;&#305;la&#351;&#305;lan durum konjestif kalp yetmezli&#287;i olanlarda
Cheyne-Stokes tipi santral apnedir. Obstr�ktif apneye g�re santral apne daha
nadirdir. Heterojen bir gruptur. Otonomik fonksiyon bozuklu&#287;u olan
Shy-Drager sendromu, familyal disotonomi veya diabetes mellitusta da santral
apne sendromu g�r�lebilir. Ayr&#305;ca poliomiyelit, postpolio sendromu ve
kronik n�rom�sk�ler hastal&#305;klarda izlenebilir (<b>Tablo 10</b>). Santral
uyku apnesinin PSG�deki bulgusu <b>&#350;ekil 7</b>�de belirtilmi&#351;tir.
Tedavi altta yatan nedene g�re yap&#305;l&#305;r. CPAP uygulamas&#305;na cevap
verebilir, ancak cevaps&#305;z kalanlarda BPAP uygulan&#305;r.</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:70.8pt'><span lang=TR style='font-size:
10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:TR'>&nbsp;<b><u><span
style='color:#003399'><a href="uyku7.jpg">&#350;ekil 7.</a></span></u></b>
&nbsp;Santral uyku apnesi (Kaynak 3�ten)</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:70.8pt'><span lang=TR style='font-size:
10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-bottom:none;background:#4BACC6;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;color:white;mso-ansi-language:TR'>Tablo 10. Santral uyku
  apnesi ile ili&#351;kili hastal&#305;klar</span></b><span lang=TR
  style='mso-ansi-language:TR'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>N�rolojik nedenler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:18.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Wingdings;
  mso-ansi-language:TR'>v</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Periferik sinir sistemi</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Miyopatiler</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>&nbsp;Distrofiler (Becker, fasyoskapulo-humeral,
  miyotonik , Duchenne, kav&#351;ak tipi distrofileri)</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>&#304;nflamatuvar miyopatiler</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Metabolik miyopatiler (asit maltaz
  eksikli&#287;i)</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>N�romusk�ler kav&#351;ak hastal&#305;klar&#305;</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Myasthenia gravis</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Frenik sinir tutulumu yapan n�ropatiler
  (Charcot-Marie-Tooth, difteri, varicella zoster, poliradik�lopati,
  Guillian-Barr�)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:18.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Wingdings;
  mso-ansi-language:TR'>v</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Santral sinir sistemi</span></b><span lang=DA
  style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Servikal omurilik lezyonu</span></b><span
  lang=DA style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Kanser a&#287;r&#305;s&#305;na y�nelik kordotomi</span></b><span
  lang=DA style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Travma, neoplazma, ensefalit/ menenjit sekeli</span></b><span
  lang=DA style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Siringomiyeli</span></b><span lang=DA
  style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Siringobulbi</span></b><span lang=DA
  style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Arnold-Chiari malformasyonu</span></b><span
  lang=DA style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Baziler invajinasyon</span></b><span lang=DA
  style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Platibazi</span></b><span lang=DA
  style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Vask�ler lezyonlar infarktlar, anjiomlar</span></b><span
  lang=DA style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Neoplazmalar- glioma, ganglioglioma</span></b><span
  lang=DA style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Beyinsap&#305;na bas&#305; yapan serebellar
  lezyonlar- hematom, subdural veya epidural hematom</span></b><span lang=DA
  style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Beyinsap&#305;na bas&#305; yapan kortikal ve
  subkortikal lezyonlar- subdural veya epidural hematom, serebral kont�zyon,
  intrakranyal abse, neoplazma</span></b><span lang=DA style='mso-ansi-language:
  DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:18.0pt'><b><span lang=TR
  style='font-size:9.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></b><span lang=DA style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:18.0pt'><b><span lang=TR
  style='font-size:9.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></b><span lang=DA style='mso-ansi-language:DA'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:18.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Wingdings;
  mso-ansi-language:TR'>v</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Kombine lezyonlar</span></b><span lang=DA
  style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Leigh ensefalopatisi ve mitokondriyal miyopati</span></b><span
  lang=DA style='mso-ansi-language:DA'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Poliomiyelit</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Amyotrofik lateral skleroz</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=614 valign=top style='width:460.6pt;border-top:none;border-left:
  solid #4BACC6 1.0pt;border-bottom:none;border-right:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:18.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Wingdings;
  mso-ansi-language:TR'>v</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Otonomik sinir sistemi</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Konjenital santral hipoventilasyon sendromu</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Kazan&#305;lm&#305;&#351; santral
  hipoventilasyon sendromu</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Ailesel disotonomi (Riley-Day)</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Shy-Drager sendromu</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Diyabet, kronik b�brek yetmezli&#287;i ile
  ili&#351;kili otonomik n�ropati</span></b></p>
  <p class=MsoNormal style='margin-left:72.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Obezite-hipoventilasyon sendromu (Pickwick
  sendromu)</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>N�rolojik olmayan nedenler</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8;mso-yfti-lastrow:yes'>
  <td width=614 valign=top style='width:460.6pt;border:solid #4BACC6 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Kronik obstr�ktif akci&#287;er
  hastal&#305;&#287;&#305;</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Konjestif kalp yetmezli&#287;i</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Metabolik hastal&#305;klar (�remi,
  hipotiroidizm)</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>Y�ksek rak&#305;m</span></b></p>
  <p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
  lang=TR style='font-size:9.0pt;line-height:115%;font-family:Symbol;
  mso-ansi-language:TR'>�</span><span lang=TR style='font-size:7.0pt;
  line-height:115%;font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span><b><span lang=TR style='font-size:9.0pt;line-height:115%;font-family:
  Tahoma;mso-ansi-language:TR'>&#304;la�lar (opiyat, �ocuklarda fenotiyazin
  kullan&#305;m&#305;, preterm bebeklerde spinal anestezi) </span></b></p>
  <p class=MsoNormal><b><span lang=TR style='font-size:9.0pt;line-height:115%;
  font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=TR style='font-size:9.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0cm 0cm 20.0pt 0cm'>

<p class=MsoNormal><b><i><span lang=TR style='font-size:10.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>�st Solunum Yolu Rezistans
Sendromu:</span></i></b><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'> Yeni tan&#305;mlanm&#305;&#351; olan
bu sendrom, uykuda �nemli solunum anormalli&#287;i veya hemoglobin oksijen
desat�rasyonu yapmaks&#305;z&#305;n uykunun aral&#305;klarla b�l�nmesi ile
karakterizedir. Hastalar&#305;n s&#305;kl&#305;kla yak&#305;nmalar&#305;
uykusuzluk, uyku b�l�nmesi ve yorgunluktur. Y�ksek oranda anksiyete
g�sterirler. Fizik muayenede so&#287;uk ekstremiteler, postural hipotansiyon,
bitkin kalma, d�&#351;�k kan bas&#305;nc&#305;, �tilt table� testinde
ortostatik hipotansiyon bulunmas&#305;, miyalji ve fonksiyonel somatik
&#351;ikayetler olur. Gece uykusunda uyanma e&#351;i&#287;i OUAS�l&#305;lara
g�re daha d�&#351;�kt�r. Solunumda �ok az bir zorlanma bile uyanmalar&#305;na
neden olur.&nbsp; Bu hastalarda uykuda alfa ritmiyle beraber delta
frekans&#305;nda yava&#351; dalgalar g�r�l�r. Bu hastalar&#305;n PSG incelemesi
s&#305;ras&#305;nda �zafageal bas&#305;n� monitorizasyonu yap&#305;larak
solunum bozuklu&#287;u indeksi hesaplamas&#305; yap&#305;lmal&#305;d&#305;r. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

</div>

<p class=MsoNormal><b><i><span lang=TR style='font-size:10.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>Obezite Hipoventilasyon Sendromu:</span></i></b><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> OUAS�l&#305; hastalar&#305;n �o&#287;unlu&#287;unda g�n i�i
hipoventilasyon olmaz.&nbsp;&nbsp; Akci&#287;er hastal&#305;&#287;&#305;na
sekonder geli&#351;meyen obez ki&#351;ide �st solunum yolu obstr�ksiyonu,
obeziteye ba&#287;l&#305; azalm&#305;&#351; solunum sistemi kompliyans&#305; ve
intrensek veya kazan&#305;lm&#305;&#351; solunum anormallikleri etyolojideki en
�nemli nedenlerdir. &#304;lk defa Pickwick sendromu olarak tariflenmi&#351;tir.
Apne veya hipopne olmamas&#305;na kar&#351;&#305;n hipoventilasyon vard&#305;r.
�ok heterojen bir sendromdur. Baz&#305; hastalar sadece CPAP ile yeterli
&#351;ekilde tedavi edilirken, baz&#305;lar&#305;nda ise di&#287;er tedavi
se�enekleri BPAP, sadece mekanik ventilasyon, veya mekanik ventilasyon
deste&#287;inde oksijen iyi gelebilir. G�n i�i hipoventilasyonu varsa azaltmak
i�in solunum uyar&#305;c&#305;s&#305; olan medroksiprogesteron verilebilir.
Ancak bu ila� solunum bozukluk indeksini azaltmaz. </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>NARKOLEPS&#304;</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&#304;lk kez 1880 Gelineu
taraf&#305;ndan primer psikiyatri hastal&#305;&#287;&#305; olarak
tariflenmi&#351;tir. Prevalans&#305; 1/2000 olup Parkinson ve Multipl skleroz
kadar s&#305;k g�r�len bir hastal&#305;kt&#305;r. &nbsp;Japonya�da be&#351; kat
yayg&#305;n iken &#304;srail�de 1/500.000 dir. Ancak, �ok iyi
sorgulanmad&#305;&#287;&#305; i�in tan&#305;s&#305; konamayan bir
hastal&#305;kt&#305;r. Bazen hastal&#305;&#287;&#305;n fark edilmesi
y&#305;llar&#305; alabilir. Cinsiyet fark&#305; g�r�lmez. Narkolepsi
uyku-uyan&#305;kl&#305;&#287;&#305;n belirlenmesindeki kontrol�n
kayboldu&#287;u bir bozukluktur. &#304;dyopatik ve semptomatik olarak ikiye
ayr&#305;l&#305;r. &#304;dyopatik olanlarda n�rolojik muayene ve kranyal g�r�nt�lemenin
normal olmas&#305; gereklidir. Semptomatik olanlarda patolojik s�re� genellikle
hipotalamik b�lgeye yak&#305;n t�m�rler nedeniyle olu&#351;ur ve �ok nadirdir.
&nbsp;&nbsp;Katapleksi ile beraber narkolepsisi olan ki&#351;ilerin
%90�&#305;ndan fazlas&#305;nda spesifik olarak HLA DR2/DQ1( HLA-DR15 ve
HLA-DQ6) izlenmektedir. Bu aday gen toplumun &lt; %30 g�r�l�r. Narkolepsisi
olanlar&#305;n karde&#351;lerinde hastal&#305;k g�r�lme riski 60 kez artar.
Genetik komponent kesin olsa da bu komponent hastal&#305;k i�in ne gereklidir
ne de yeterlidir. &#304;nsanlar&#305;n d&#305;&#351;&#305;nda kedi, k�pek, at
ve Guernsey bo&#287;alar&#305;nda da bildirilmi&#351;tir. Narkolepsi ve
katapleksisi olan k�pekler insanlar i�in �ok de&#287;erli hayvan modellerini
olu&#351;turmaktad&#305;rlar. &nbsp;Bu modeller ve insanda yap&#305;lan
hipokretin gen ve resept�rlerin belirlenmesi katapleksi ile giden narkolepsinin
lateral hipotalamusta hipokretin �reten n�ronlar&#305;n kayb&#305;na
ba&#287;l&#305; oldu&#287;unu ortaya koymu&#351;tur. Hipokretin (oreksin),
uyan&#305;kl&#305;&#287;&#305;n devam&#305;, uyku-uyan&#305;kl&#305;k siklusu,
kas tonusu reg�lasyonu, lokomosyon, n�roendokrin ve otonomik
mekanizmalar&#305;n da i�inde oldu&#287;u bir�ok farkl&#305; fonksiyona sahiptir.
Uyan&#305;kl&#305;k, REM ve NREM aras&#305;ndaki uygunsuz ge�i&#351;leri
�nleyerek anahtar rol� oynayan hipokretin terimi, k�ken olarak hipotalamusun
hipo- ve sekretinin �kretin�inden olu&#351;mu&#351;tur. Katapleksisi olan
narkoleptik hastalarda BOS�ta hipokretin d�zeyi d�&#351;�kt�r veya hi�
bulunmamaktad&#305;r. Hipotalamusta hipokretin salg&#305;layan n�ronlar&#305;n
n�rodejeneratif veya otoimm�n bozuklu&#287;a ba&#287;l&#305; olarak ortaya
�&#305;kabilece&#287;i y�n�nde g�r�&#351;ler belirmi&#351;tir. &#304;nme,
hipotalamik neoplazma (kranyofarengioma), hipotalamusu i�ine alan ADEM veya
multipl skleroza sekonder semptomatik hipersomnilerde de BOS hipokretin d�zeyi
d�&#351;�k �&#305;kabilir. �ok nadir olarak Prader-Willi sendromu ve
Niemann-Pick hastal&#305;&#287;&#305;n&#305;n C tipinde de (katapleksiye benzer
epizodlarla birlikte) d�&#351;�k BOS hipokretin d�zeyleri bildirilmi&#351;tir.
Ba&#351;ka uyku bozukluklar&#305;nda da BOS hipokretin d�zeyleri �l��lm�&#351;,
yap&#305;lan meta analizlerde idyopatik hipersomnilerin %8�inde, obstr�ktif
uyku apnesi olanlar&#305;n %3��nde BOS hipokretin d�zeyi d�&#351;�k bulunmu&#351;tur.
Huzursuz bacak sendromu ve Kleine-Levin sendromu olanlarda d�zeyin normal
oldu&#287;u saptanm&#305;&#351;t&#305;r.&nbsp; </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Ba&#351;lang&#305;� ya&#351;&#305;
genellikle ergen ve gen� eri&#351;kin �a&#287; olmakla birlikte 3 ile 72
ya&#351; aras&#305;nda g�r�lebilir. Hastal&#305;&#287;&#305;n en �nemli
semptomlar&#305;ndan birisi, <i>g�n i�i a&#351;&#305;r&#305; uyku</i>
ataklar&#305;d&#305;r. Bu uyku ataklar&#305; beklenmedik veya istenmedik
yerlerde ve uygunsuz zamanlarda saniyeler veya dakikalar s�rer. �zellikle
�evresel uyaran&#305;n azald&#305;&#287;&#305; kitap okuma, televizyon seyretme
s&#305;ras&#305;nda, bisiklet veya ara� kullan&#305;rken veya s&#305;n&#305;fta
ders dinlerken ortaya �&#305;kar. K&#305;sa g�nd�z uykusu uyumak
dinlendiricidir. Uyaran&#305;n �ok oldu&#287;u d�nemlerde de �n�ne ge�ilemeyen
uyku ataklar&#305; olabilir. �rne&#287;in yemek yerken, di&#351;�i
koltu&#287;unda m�dahale yap&#305;l&#305;rken veya �ok heyecanl&#305; bir
ma�&#305;n son dakikalar&#305;n&#305; izlerken ki&#351;i uyuyabilir. Uyku
ataklar&#305; �ncesi ki&#351;i �ift g�rme ve bulan&#305;k g�rme sonras&#305;
uykuya dalar. Bu &#351;ikayetle genellikle ilk olarak oftalmologa giderler.
Di&#287;er semptom <i>katapleksi</i>dir. Bilin�te de&#287;i&#351;iklik olmadan
istemli kaslarda ani ba&#351;lang&#305;�l&#305; paralizi ya da g�� kayb&#305;
olmas&#305;d&#305;r. Hastalar&#305;n %65-70�i g�lme, heyecanlanma, sinirlenme
veya bir s�rprizle kar&#351;&#305;la&#351;ma sonras&#305; ani kas tonusu
kayb&#305; ile d�&#351;me veya oldu&#287;u yere y&#305;&#287;&#305;lma tarif
eder. Postiktal konf�zyon olmaz, t�m olay&#305; hat&#305;rlarlar. Semptomlar
�ok hafif olup fokal kalabilir ve sadece baz&#305; kaslar&#305; tutabilir.
Solunum kaslar&#305; tutulmaz. &nbsp;A&#287;&#305;zda kayma,
konu&#351;man&#305;n peltekle&#351;mesi, ekstremitede lokalize zaaf veya
dizlerinin ��z�lmesi gibi klinik belirtiler verebilir. Saniyeler s�rer ve bilin�te
de&#287;i&#351;iklik olmaz. Hastan&#305;n katapleptik atak
s&#305;ras&#305;ndaki muayenesinde yayg&#305;n hipotoni ile birlikte paralizi,
derin tendon reflekslerinin kayboldu&#287;u, kornea refleksinin
azald&#305;&#287;&#305;, &#305;&#351;&#305;k refleksinin korundu&#287;u ve
fazik kas se&#287;irmelerinin oldu&#287;u g�r�l�r. Ge�ici iskemik atak, n�bet
veya psikojenik bir atak zannedilebilir. Katapleksi s&#305;ras&#305;nda r�ya
g�r�lebilir ve bu durum hekim taraf&#305;ndan yanl&#305;&#351;
de&#287;erlendirilerek hal�sinasyon zannedilip &#351;ifozreni tan&#305;s&#305;
bile konabilir. Narkolepsili hastalar&#305;n %30�unda katapleksi hi� olmaz,
olanlarda da a&#351;&#305;r&#305; uyku ataklar&#305;n&#305;n �ncesinde veya
y&#305;llar sonras&#305;nda ortaya �&#305;kabilir. Narkolepsili hastalar&#305;n
%60�&#305;nda uyku paralizisi olur. Genellikle uykudan REM evresi ile uyanma ve
bunun ard&#305;ndan t�m v�cutta paralizisi olur. Olay s&#305;ras&#305;nda
a&#351;&#305;r&#305; korku duyar. Solunum ve g�z hareketlerinin korundu&#287;u
uyku paralizisi saniyeler ile dakikalar aras&#305; s�rer. Sadece
d&#305;&#351;ar&#305;dan basit bir dokunma ile uyku paralizisi sonlan&#305;r.
Uyku paralizisinin REM uykusu s&#305;ras&#305;nda olu&#351;an motor inhibisyon
ile ayn&#305; mekanizmadan kaynakland&#305;&#287;&#305;
d�&#351;�n�lmektedir.&nbsp; Uykusuz kalm&#305;&#351; sa&#287;l&#305;kl&#305;
bireylerde de narkolepsi olmadan uyku paralizisi olur. Depresyon
hastalar&#305;nda s&#305;k rastlan&#305;r. &nbsp;<i>Hipnogojik</i> (uykuya
dalarken) ve <i>hipnopompik</i> (uykudan uyan&#305;rken) <i>hal�sinasyonlar</i>
di&#287;er klinik belirtilerdendir. Hastalar&#305;n %12-50�sinde izlenir. Bu
hal�sinasyonlar uyku ve uyan&#305;kl&#305;k d�nemi aras&#305;ndaki ge�i&#351;
s&#305;ras&#305;nda canl&#305; ve �o&#287;unlukla �rk�t�c� olabilir. Uyku
paralizisi ile birlikte olunca korku daha yo&#287;un ya&#351;an&#305;r. Basit
veya kompleks g�rsel, i&#351;itsel veya taktil &#351;ekilde olabilir. Uyku
paralizisinde �evrenin fark&#305;nda olmalar&#305;na kar&#351;&#305;n bu
hal�sinasyonlar&#305; ger�ekten ay&#305;rt etmekte zorluk �ekebilirler. Normal
ki&#351;ilerde de uyku yoksunlu&#287;u, ila�lar ve alkol nedeniyle ayn&#305;
tip hal�sinasyonlar g�r�lebilir. Hastalar&#305;n %80�inde otomatik
davran&#305;&#351;lar vard&#305;r. Uyan&#305;kl&#305;&#287;&#305; mikro
uykularla kesintiye u&#287;rad&#305;&#287;&#305; d�nemlerde uzun s�reli
kendisinin hat&#305;rlamad&#305;&#287;&#305; �bellek bo&#351;luklar&#305;� veya
�film kopmas&#305;� olarak tariflenen kompleks davran&#305;&#351;lar yapar.
Araba kullan&#305;m&#305; s&#305;ras&#305;nda kaybolabilir.&nbsp; Anlams&#305;z
c�mleler s�yleyebilir, acayip c�mleler yazabilir, garip davran&#305;&#351;lar
sergileyebilir. Yanl&#305;&#351;l&#305;kla kompleks parsiyel n�bet veya
psikojenik f�g olarak de&#287;erlendirilebilir. Tan&#305;y&#305; koymak i�in
t&#305;pk&#305; di&#287;er n�roloji hastal&#305;klar&#305;nda
yap&#305;ld&#305;&#287;&#305; gibi hikayeyi ayr&#305;nt&#305;l&#305; dinlemek
gereklidir. Katapleksi, narkolepsi i�in patognomoniktir. Ancak her hastada
g�r�lmez. Narkolepsiyi d�&#351;�nd�ren �yk�s� olan hastada objektif uyku
laboratuar testlerinin yap&#305;lmas&#305; ile tan&#305; konur. PSG ba&#351;ka
uyku bozukluklar&#305;n&#305;n tan&#305;s&#305; i�in de kullan&#305;l&#305;r.
Gece yap&#305;lan PSG�de k&#305;sa uyku latans&#305; ve bozulmu&#351; uyku
kalitesi ile birlikte NREM evre 1�de artma ve NREM evre 3-4�de ise azalma
g�r�l�r. REM uyku s�resinde de&#287;i&#351;iklik olmaks&#305;z&#305;n toplam
uyku zaman&#305; azalm&#305;&#351; olabilir. Yap&#305;lan
�al&#305;&#351;malarda narkolepsisi olanlar ve normal ki&#351;ilerin toplam
uyku zamanlar&#305; aras&#305;nda bir farkl&#305;l&#305;&#287;&#305;n
olmamas&#305;na kar&#351;&#305;n narkolepsisi olanlar&#305;n g�n i�inde geceye
g�re daha fazla uyuduklar&#305; belirlenmi&#351;tir. T�m gece PSG ve sonraki
g�n ise multipl uyku latans testi (MULT) yapmak gereklidir. MULT narkolepsi
tan&#305;s&#305; koymakta ve uykululu&#287;u de&#287;erlendirmede standart
objektif bir testtir. MULT incelemesinde uyku latans&#305; tipik olarak 5
dakika veya 5 dakikan&#305;n alt&#305;na inmi&#351;tir. Genellikle uykuya
giri&#351; REM uykusu ile olur. </span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Narkolepsi hastal&#305;&#287;&#305;
hem hasta hem de aile i�in �ok �nemli sosyal, ekonomik ve e&#287;itime ait
sorunlar olu&#351;turabilir. Zekalar&#305;nda bir sorun olmamas&#305;na
kar&#351;&#305;n bu potansiyellerini g�steremezler. E&#287;itim, meslek ve
evliliklerinde s&#305;k�a sorunlar �&#305;kar. Bu ki&#351;ileri
de&#287;erlendiren aile bireyleri ve arkada&#351;lar&#305; bu durumlar&#305;
genellikle tembellik, h&#305;rsl&#305; olmamak, olgunla&#351;ma ve psikolojik
sorun olarak a�&#305;klamaya �al&#305;&#351;&#305;rlar. </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Tedavi:</span></i><span lang=TR
style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> &#304;la� d&#305;&#351;&#305; tedavide yap&#305;lmas&#305; gerekenler
yeterli uyku uyumak, iyi uyku hijyenini sa&#287;lamak ve
programlanm&#305;&#351; k&#305;sa g�nd�z uykular&#305; uyumakt&#305;r. &#304;la�
olarak uyaran �zellikli droglar se�ilir. Metamfetamin, dekstroamfetamin ve
metilfenidat �ok etkilidir. Modafinil orta d�zeyde, pemolin ise daha az
etkilidir. Ancak metamfetamin, dekstroamfetamin ve metilfenidat&#305;n etkileri
al&#305;mdan 1-3 saat sonra ba&#351;lar. Yan etki sinirlilik,
ba&#351;a&#287;r&#305;s&#305;, i&#351;tahs&#305;zl&#305;k,
�arp&#305;nt&#305;d&#305;r. Tolerans geli&#351;ebilir. Y�ksek dozlarda bile
etkisini kaybedebilir. &#304;la� tatili verilerek tekrar ba&#351;lanabilir. Kan
bas&#305;nc&#305;n&#305; artt&#305;rabilirler. Bu ila�lar&#305;n yatarken
al&#305;nmamas&#305; gereklidir. Uzun etkili olduklar&#305;ndan insomni
yapabilir. Hal�sinasyon ve paranoya olabilir. Modafinil etki mekanizmas&#305;
pek bilinmeyen ve uyaran �zelli&#287;i olmayan bir ila�t&#305;r. Ekstrasell�ler
GABA konsantrasyonunu azalt&#305;r. Uyan&#305;kl&#305;&#287;&#305; artt&#305;ran
tuberomammiller n�ronlar&#305; aktive eder. Yan etki
ba&#351;a&#287;r&#305;s&#305;, bulant&#305; ve sinirliliktir. MAO-B inhibit�r�
selejilin di&#287;er bir alternatiftir. Hipertansif krize kar&#351;&#305;
tiramin al&#305;m&#305; d�&#351;�k tutulmal&#305;d&#305;r. Narkolepsi ile
katapleksisi olan hastalarda kullan&#305;lacak ila�lar di&#287;er
semptomlar&#305; da (uyku paralizisi, hipnogojik hal�sinasyonlar&#305;)
bask&#305;lar. Trisiklik antidepresanlar (protriptilin, klomipramin,
imipramin), selektif serotonin gerial&#305;m inhibit�r� (fluoksetin), selektif
olmayan&nbsp; serotonin gerial&#305;m inhibit�r� (venlaflaksin), &nbsp;ve
di&#287;er ila�lar (selejilin, sodyum oksibat) etkili olurlar. Epworth uyku
skalas&#305; ile tedavi etkisi de&#287;erlendirilir.</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><i><span lang=TR style='font-size:10.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>&#304;dyopatik Hipersomni:</span></i></b><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> Heterojen bir gruptur. Sabah uykudan uyanmada zorluk, k&#305;sa g�nd�z
uykular&#305; ile kendine gelememe halidir.. Baz&#305; hastalarda buna ilave
uyku paralizisi ve hipnogojik hal�sinasyonlar vard&#305;r. &nbsp;Yap&#305;lan
incelemelerde (PSG ve MULT) objektif hipersomnolans&#305;n
d&#305;&#351;&#305;nda anormallik g�r�lmez. </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Rek�ren hipersomniler olarak
Kleine-Levin sendromu, menstruasyona ba&#287;l&#305; hipersomni, idyopatik
rek�ran (endozepin) stuporu di&#287;er hipersomniler aras&#305;nda
say&#305;labilir. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>HUZURSUZ BACAK SENDROMU (HBS, �<i>Restless
Legs Syndrome</i>�):</span></b><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&#304;lk kez 17. y�zy&#305;lda
tan&#305;mlanan HBS, s&#305;k g�r�len ve uyku bozukluklar&#305; i�inde �nemli
nedenlerinden biridir. Ekstremitelerde en �ok bacaklarda ho&#351; olmayan ve dizestezi
ile karakterize bir sendromdur. Bu ho&#351; olmayan ve rahats&#305;zl&#305;k
verici hisse kar&#351;&#305; konulmaz hareket etme ihtiyac&#305; vard&#305;r ve
hareket yapmak ki&#351;iyi motor huzura kavu&#351;turur. Semptomlar
�o&#287;unlukla istirahat halinde iken olur ve ki&#351;i hareket etti&#287;inde
bu anormal duyumun ortadan kalkmas&#305; tipik, tan&#305; koyduran �zelliktir.
HBS idyopatik ve semptomatik olarak ikiye ayr&#305;l&#305;rlar. En �ok
idyopatik grup HBS g�r�l�r ve bu gruptaki hastalar&#305;n birinci derece
akrabalar&#305;n&#305;n %50�den fazlas&#305;nda bu hastal&#305;&#287;&#305;n
g�r�lmesi genetik ge�i&#351;i desteklemektedir. </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Ekbom taraf&#305;ndan yap&#305;lan
�al&#305;&#351;mada tahminen prevalans&#305;n %5.2 oldu&#287;u
belirtilmi&#351;tir. Daha sonraki �al&#305;&#351;malarda %9.8-27 olarak
g�sterilmi&#351;tir. Ya&#351; artt&#305;k�a prevalans&#305;n y�kseldi&#287;i
belirlenmi&#351;tir. Yap&#305;lan bir �al&#305;&#351;mada hastalar&#305;n
%45�inde 20 ya&#351;&#305;ndan �nce ilk semptomlar&#305;n ortaya
�&#305;kt&#305;&#287;&#305; belirtilmektedir. HBS semptomlar&#305;n&#305;n
ortalama ba&#351;lang&#305;� ya&#351;&#305; 27 olarak bildirilse de %13��nde
semptomlar 10 ya&#351;&#305;ndan �nce ortaya �&#305;kmaktad&#305;r. Y�ksek
penetrans&#305; olan otozomal dominant ge�i&#351; g�stermektedir.
Ba&#287;lant&#305; analizlerinde HBS i�in kromozom 12 q ve 14 q ile
ili&#351;kili bulunmu&#351;tur. Yeni ku&#351;aklarda antisipasyon
izlenmektedir. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Dopaminerjik&nbsp; hipofonksiyon
bozuklu&#287;unu ilk kez Dr &#350;evket Akp&#305;nar taraf&#305;ndan ortaya
konmu&#351;tur. L-Dopa tedavisi ile semptomlar&#305;n ortadan
kalkt&#305;&#287;&#305;n&#305;n g�sterilmesi hem patofizyoloji hem de
n�rofarmakoloji a�&#305;s&#305;ndan yeni bir ufuk a�m&#305;&#351;t&#305;r.
Dopaminerjik hipofonksiyon g�r�nt�leme �al&#305;&#351;malar&#305; ile de
desteklenmi&#351;tir. Bu hastal&#305;kta bir ba&#351;ka �nemli nokta ise
sirkadyen ritm �zelli&#287;idir. Patofizyolojisine ait �zellikle fonksiyonel
g�r�nt�lemelerle yap&#305;lan �al&#305;&#351;malarda etyolojik fakt�r
g�sterilememi&#351;tir. Yap&#305;lan �al&#305;&#351;malar&#305;n sonucu HBS�nin
patofizyolojisinde omurilik ile bazal ganglionlar aras&#305;nda kalan sinir
sistemi b�lgesinin rol oynad&#305;&#287;&#305; d�&#351;�n�lmektedir.
&nbsp;HBS�nun beyinsap&#305; d�zeyinde ortaya �&#305;kan ve spinal
eksitabilitede de&#287;i&#351;ikliklere neden olan supraspinal ritmin
par�as&#305; oldu&#287;u ve burada dopamin ve demir
azl&#305;&#287;&#305;n&#305;n rol oynad&#305;&#287;&#305; belirtilmektedir.
Yap&#305;lan beyin omurilik s&#305;v&#305;s&#305; �al&#305;&#351;malar&#305;nda
ferritin ve transferrin de&#287;erlerinin d�&#351;�k oldu&#287;u ve bu da
d�&#351;�k beyin demirinin indirekt bulgusu oldu&#287;u iddia edilmi&#351;tir.</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;<i>Tan&#305; kriterleri: </i></span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Uluslararas&#305; HBS
�al&#305;&#351;ma grubunun 1995 y&#305;l&#305;nda belirledi&#287;i klinik
�zellikler, 2002 y&#305;l&#305;nda ABD Ulusal Sa&#287;l&#305;k Enstit�s��ndeki
�al&#305;&#351;tayda tekrar g�zden ge�irilerek d�zenlenmi&#351;tir. &nbsp;D�rt
temel kriter ve bunlara ilave olarak destekleyici ve yard&#305;mc&#305;
�zellikler belirlenmi&#351;tir. HBS tan&#305;s&#305; i�in laboratuvar testi
yoktur. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>1-Bacaklarda ho&#351; olmayan ve
rahats&#305;zl&#305;k verici his ile birlikte olan hareket etme iste&#287;i (
bazen ho&#351; olmayan his olmayabilir veya bazen bacaklara ek olarak kollar
veya di&#287;er v�cut b�lgelerinde de olabilir)</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>2-Hareket etme iste&#287;i veya
ho&#351; olmayan his, hareketsizlik veya istirahat d�nemlerinde, yatma ve oturma
s&#305;ras&#305;nda artar.</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>3-Hareket etme iste&#287;i veya
ho&#351; olmayan his hareketle (y�r�mek ve gerinmek gibi) k&#305;smen veya
tamamen rahatlar ve en az&#305;ndan hareket devam etti&#287;i s�resince
azal&#305;r.</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>4- Hareket etme iste&#287;i veya
ho&#351; olmayan his ak&#351;am veya gece ortaya �&#305;kar veya g�nd�ze g�re
art&#305;&#351; g�sterir (semptomlar �ok &#351;iddetli ise geceleri
k�t�le&#351;me belirgin olmayabilir, fakat hastal&#305;&#287;&#305;n �nceki
d�nemlerinde bu kriter mutlaka olmal&#305;d&#305;r).</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Destekleyici �zellikler:</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>1-Dopaminerjik tedaviye yan&#305;t</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>2-Periyodik ekstremite hareketlerinin
olmas&#305; (uyan&#305;kl&#305;k veya uykuda)</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>3-Aile �yk�s�</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Yard&#305;mc&#305; �zellikler</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>1-Progresif klinik gidi&#351;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>2-Fizik muayene</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>3-Uyku bozukluklar&#305;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Ho&#351; olmayan ve
rahats&#305;zl&#305;k verici hisler yan&#305;c&#305;, bat&#305;c&#305;, krampa
benzer, t&#305;rman&#305;c&#305; &#351;ekilde ve a&#287;r&#305;n&#305;n da
e&#351;lik etti&#287;i durumlard&#305;r.. Tek bacak, iki bacak veya bazen t�m
ekstremitelerde olur. Sadece kollarda olmas&#305; �ok nadirdir. Baz&#305;
hastalar ho&#351; olmayan ve rahats&#305;zl&#305;k verici hisler
olmaks&#305;z&#305;n sadece bacaklar&#305;n&#305; hareket ettirme
iste&#287;inden bahsederler. Di&#287;er hareket bozukluklar&#305;ndan
farkl&#305; olarak HBS�de istirahatte veya inaktif durumdayken semptomlar
ka�&#305;n&#305;lmaz bir &#351;ekilde ortaya �&#305;kar. Bu hissin yok
olmas&#305; i�in ayaklar&#305; ovu&#351;turmak veya sert bir zemine vurmak
i&#351;e yarayabilir.&nbsp; En �ok y�r�mek semptomlar&#305; ani &#351;ekilde
durdurur. Semptomlar g�n�n 24 saati i�inde her saat olabilir. Genellikle
hastal&#305;&#287;&#305;n ileri d�nemlerinde g�n i�inde de semptomlar g�r�lmeye
ba&#351;lar. Uzun d�nemde g�nd�z ve gece aras&#305;nda semptomlar
a�&#305;s&#305;ndan fark yoktur. Baz&#305; hastalar bacaklar&#305;n&#305;n
istemsiz olarak hareket etti&#287;ini bildirirler.&nbsp; HBS�lu hastalar
ho&#351; olmayan bir his ile uyan&#305;p semptomlar&#305; rahatlad&#305;ktan
sonra uyuyabilirler. Bu durum gece i�inde tekrarlayabilir ve uyku sorunu ortaya
�&#305;kar. Hastalar&#305;n %94��nde uykuya dalma ve uykuyu s�rd�rmede zorluk,
%87�sinde sadece uykuya dalmakta zorluk, %86�s&#305;nda ise sadece uykuyu
s�rd�rmede zorluk yak&#305;nmas&#305; olur.&nbsp; </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><i><span lang=TR style='font-size:12.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>Semptomatik HBS:</span></i></b><span
lang=TR style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> &#304;dyopatik grubun d&#305;&#351;&#305;nda �ok az hastada baz&#305;
hastal&#305;klarla birlikte bulunmaktad&#305;r.&nbsp; �remi, n�ropati ve demir
eksikli&#287;i anemisi en s&#305;k g�r�lmekle birlikte, daha nadir olarak
romatoid artrit, diabetus mellitus, hiper ve hipotiroizm, kronik akci&#287;er
hastal&#305;klar&#305;, l�semi, Isaacs sendromu g�r�l�r. Ayr&#305;ca n�rolojik
hastal&#305;klar a�&#305;s&#305;ndan periferik n�ropati, radik�lopati,
miyelopati, omurilik tutulumu ile giden multipl skleroz, omurilik
bas&#305;lar&#305;, Parkinson hastal&#305;&#287;&#305;, L-dopa�ya
yan&#305;tl&#305; distoni, n�roleptik kullan&#305;m&#305;na ba&#287;l&#305;
akatizi, stiff-person sendromu, Huntington hastal&#305;&#287;&#305; ve amiyotrofik
lateral skleroz say&#305;labilir.&nbsp; Tourette sendromu ve �ocuklarda dikkat
eksikli&#287;i hiperaktivite sendromu ile HBS birlikteli&#287;i
bildirilmi&#351;tir. Hemodialize giren �remik hastalar&#305;n %15-40�&#305;nda
HBS g�r�l�r ve semptomlar&#305; �ok a&#287;&#305;rd&#305;r. Hemodializ
s�resince uzun s�reli immobilizasyon bu hastalar i�in �ok dramatiktir. �remik
hastalarda beraberinde n�ropati ve aneminin de olmas&#305;nda hemodializin rol
oynad&#305;&#287;&#305; d�&#351;�n�lmektedir. Ba&#351;ar&#305;l&#305; b�brek
transplantasyonu sonras&#305; HBS semptomlar&#305; tamamen kaybolur.
Semptomatik HBS d�&#351;�n�len hastalar&#305;n �yk�s� derinle&#351;tirilmeli,
fizik ve n�rolojik muayenesi ayr&#305;nt&#305;l&#305; &#351;ekilde
yap&#305;lmal&#305; ve tetkikleri tamamlanmal&#305;d&#305;r. Fizyolojik bir
durum olan gebelikte de HBS g�r�lebilir.</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>HBS�nin &#351;iddetini belirlemek ve
tedavi alt&#305;nda izlenmesini kolayla&#351;t&#305;rmak amac&#305;yla
kullan&#305;lan John Hopkins&nbsp; &#351;iddet skalas&#305;na g�re semptomlar
0-3 aras&#305;nda de&#287;erlendirilir. 0: semptomsuz, 1: sadece gece
semptomlar&#305;n olmas&#305;, 2: sadece ak&#351;am saatlerinde (18:00�den
sonra), 3: saat 18:00�den �nce semptomlar&#305;n ortaya �&#305;kmas&#305;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Tedavi:</span></i><span lang=TR
style='font-size:12.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> Semptomatik grupta altta yatan neden tedavi edildi&#287;inde HBS�de
iyile&#351;ecektir. Tam d�zelme bile olabilece&#287;inden ila� dozunun
d�&#351;�k tutulmas&#305; gereklidir. Dopaminerjik ila�lar (L-dopa, pergolid,
pramipeksol, ropinirol), sedatif-hipnotikler (klonazepam, estazolam, oksazepam,
temazepam, triazolam, zaleplon, zolpidem), antikonv�lzanlar (karbamazepin,
gabapentin), opioidler (propoksifen, hidrokodon, kodein, tramadol, oksikodon,
metadon, morfin sulfat) HBS�de kullan&#305;l&#305;r. Dopaminerjik ila�lar
d�&#351;�k dozda al&#305;mdan k&#305;sa s�re sonra etkisini g�sterir. Opioidler
�ok g��l� etkiye sahiptir ve tedaviye diren�li olgularda olduk�a etkili
ila�lard&#305;r. Ancak ba&#287;&#305;ml&#305;l&#305;k a�&#305;s&#305;ndan
k&#305;sa s�reli kullan&#305;m tavsiye edilir. Benzodiazepinler ve �zellikle
klonazepam semptomlar&#305; belirgin d�zeltse de ba&#287;&#305;ml&#305;l&#305;k
ve tolerans yan etkileri nedeniyle s�rekli kullan&#305;lamamaktad&#305;r.
S�rekli tedavi edilmesi gerekmeyen hastalarda d�&#351;�k dozlarda �nerilir.
Antiepileptikler etkili bulunmu&#351;tur, karbamazepin ile ilgili bir�ok
�al&#305;&#351;ma vard&#305;r. Yan etkileri nedeniyle kullan&#305;m&#305;
s&#305;n&#305;rl&#305; kalabilir. Di&#287;er alternatif olarak gabapentin
vard&#305;r. Serum ferritin d�zeyi 50ng/ml�nin alt&#305;nda olan hastalarda
oral veya intraven�z demir&nbsp; verilmesi etkin olabilmektedir. Tramadol,
magnezyum s�lfat ve baklofen gibi ila�lar&#305;n etkinli&#287;i
kan&#305;tlanamam&#305;&#351;t&#305;r. Hastalar&#305;n kullanmamas&#305; gereken
ila�lar kafein, alkol, n�roleptikler, trisiklik antidepresanlar, serotonin
gerial&#305;m inhibit�rleri olan antidepresanlar, metoklopramid,
proklorperazin, droperidol ve baz&#305; kalsiyum kanal blok�rleri, buproprion
ve sedasyon yapan antihistaminiklerdir. </span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

</div>

<p class=MsoNormal><b><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>UYKUDA PER&#304;OD&#304;K
EKSTREM&#304;TE HAREKET BOZUKLU&#286;U (UPEHB)</span></b><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&#304;lk
tan&#305;mland&#305;&#287;&#305;nda nokt�rnal miyoklonus denmi&#351; ancak
periyodik hareketin karakteri ve EMG bulgular&#305; ile yeniden tan&#305;
kriterleri belirlenmi&#351;tir. Uyku s&#305;ras&#305;nda periyodik tekrarlayan,
stereotipik ayak, bacak ve /veya kol hareketlerinin oldu&#287;u bir
hastal&#305;kt&#305;r. Huzursuz bacak sendromu (HBS) ile s&#305;kl&#305;kla
birlikte g�r�l�r. Bu iki hastal&#305;&#287;&#305;n patofizyolojik olarak ortaya
�&#305;k&#305;&#351;&#305;nda benzer mekanizmalar&#305;n rol
oynad&#305;&#287;&#305;n&#305;n ortaya konmas&#305; ve HBS�nin tedavisinde
kullan&#305;lan ila�lar&#305;n bu hastal&#305;ktaki semptomlar&#305; ortadan
kald&#305;rmas&#305; bu g�r�&#351;� desteklemektedir. HBS ve UPEHB�nun
patofizyolojisinde dopaminerjik, opioderjik ve noradrenerjik n�rotransmitterler
ilk s&#305;ralarda rol almaktad&#305;rlar.&nbsp; HBS�da bahsedilen
patofizyoloji mekanizmalar&#305;n&#305;n tamam&#305;na yak&#305;n&#305;n&#305;n
UPEHB i�inde ge�erli oldu&#287;u bilinmektedir. <i>Patofizyoloji:</i> HBS
k&#305;sm&#305;na bak&#305;n&#305;z</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Klinik �zellikler:</span></i><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> UPEHB tan&#305; koydurucu tipik klinik �zellikler yoktur. Baz&#305;
hastalar kol ve bacaklarda atmalar ile uyand&#305;klar&#305;ndan
yak&#305;n&#305;rlarken, �o&#287;u sabahlar&#305; bacaklarda a&#287;r&#305;,
dinlenmemi&#351; ve yorgun uyanma veya nadiren g�nd�z uykululuk halinin
olmas&#305;ndan yak&#305;n&#305;rlar. Bazen hastan&#305;n hi�
yak&#305;nmas&#305; yok iken yatak partneri kol ve bacak hareketlerinden
dolay&#305; uykusuzluk sorunu ya&#351;ayabilir. Uykusuzluk sorunu ile
ba&#351;vuran hastas&#305;kl&#305;&#287;&#305; %18 iken, g�nd�z uykululuk hali
olan hasta %11 dir. HBS ve UPEHB hem bir arada&nbsp; hem de di&#287;er
bozukluklar ile komorbid olabilirler. UPEHB en s&#305;k NREM uykuda
olu&#351;ur. Di&#287;er hareket bozukluklar&#305;n&#305;n aksine uykuyla
hareketler ba&#351;lar. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Tan&#305; kriterleri:</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>1-polisomnografide
a&#351;a&#287;&#305;daki �zelliklerde tekrarlayan, �ok stereotipik ekstremite
hareketleri g�zlenir</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>a.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>0.5-5 saniye s�reli</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>b.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>Ayak ba&#351;parma&#287;&#305; dorsifleksiyonu (kalibrasyonun %25�ine
e&#351;it veya daha b�y�k amplit�dl�)</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>c.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>4 veya daha fazla hareket i�eren hareket sekans&#305;</span><span lang=DA
style='mso-ansi-language:DA'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt'><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>d.</span><span lang=TR style='font-size:7.0pt;line-height:115%;font-family:
"Times New Roman";mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>5 saniyeden uzun ve 90 saniyeden daha k&#305;sa aral&#305;kla tekrarlayan
hareketler (ekstremite hareketi ba&#351;lang&#305;c&#305;ndan ekstremite
hareketi ba&#351;lang&#305;c&#305;na kadar)</span><span lang=DA
style='mso-ansi-language:DA'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>2-periyodik bacak hareketi indeksi
�ocuklarda saatte 5�in, yeti&#351;kinlerde saatte 15�in �zerindedir. </span><span
lang=DA style='mso-ansi-language:DA'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;3-klinik olarak uyku
bozuklu&#287;u veya g�nd�z yorgunluk yak&#305;nmas&#305; olur</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>4-UPEHB olanlarda ba&#351;ka bir uyku
bozuklu&#287;u, medikal veya n�rolojik bozukluk, mental bozukluk, ila�
kullan&#305;m&#305; veya madde kullan&#305;m&#305; ile a�&#305;klanamaz (klinik
apnelerin sonunda ortaya �&#305;kan periyodik ekstremite hareket bozuklu&#287;u
UPEHB olarak de&#287;erlendirilmemelidir)</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Tedavi:</span></i><span lang=TR
style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> HBS�ye bak&#305;n&#305;z</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>�E&#350;&#304;TL&#304; N�ROLOJ&#304;K
HASTALIKLARDA G�R�LEN UYKU BOZUKLUKLARI</span></b><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><i><span lang=TR style='font-size:10.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>Parkinsonizm:</span></i></b><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>&nbsp; Uyku yak&#305;nmas&#305;, bozulmu&#351; ya&#351;am kalitelerinin
daha da bozulmas&#305;na neden olur. Bu hastal&#305;&#287;&#305;n
patofizyolojisindeki dopaminerjik n�ron kayb&#305; hem Parkinson
hastal&#305;&#287;&#305;na yol a�arken hem</span><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'> de uyku-uyan&#305;kl&#305;k </span><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>bozukluklar&#305;na da neden olur. <b>Tablo 11</b>� de Parkinson
hastal&#305;&#287;&#305;nda g�r�len semptomlar&#305;n neden sonu� ili&#351;kisi
g�sterilmi&#351;tir.</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Tablo 11.Parkinson
hastal&#305;&#287;&#305;nda g�r�len semptomlar&#305;n neden sonu� ili&#351;kisi
</span></b><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Neden</span></b></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Sonu�</span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Kolinerjik ve monoaminerjik sistemlerin n�rokimyasal etkilenmesi</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Bozulmu&#351; uyku-uyan&#305;kl&#305;k kontrol�, azalm&#305;&#351; REM
  uykusu</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Bradikinezi ve rijidite</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Uyku s&#305;ras&#305;nda normal v�cut d�nme hareketi
  azald&#305;&#287;&#305; i�in uyanma, gece tuvaleti kullanmada zorluk
  nedeniyle rahats&#305;zl&#305;k duyma</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Periyodik bacak hareketi, tremor, ilaca ba&#287;l&#305; miyoklonus</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Uyanma</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>REM uyku davran&#305;&#351; bozuklu&#287;u</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Bozulmu&#351; REM uykusu</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Motor aktivitenin bozulmas&#305; solunum ve �st havayolu
  kaslar&#305;n&#305; etkiler</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Uykuda solunum bozukluklar&#305;</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&#304;la� etkisi</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Gece artm&#305;&#351; uyanma zaman&#305;, azalm&#305;&#351; REM uykusu</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Depresyon ve anksiyete</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Uykuya dalmakta zorluk, sabah erken uyanma</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8;mso-yfti-lastrow:yes'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Demans</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Nokt�rnal konf�zyonel epizodlar</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Hastan&#305;n semptomlar&#305;n&#305;n
do&#287;ru tan&#305;n&#305;p gerekli tetkikleri yap&#305;ld&#305;ktan sonra
uygun ila�lar&#305;n&#305;n verilmesi gereklidir. </span></p>

<p class=MsoNormal><b><i><span lang=TR style='font-size:10.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>&#304;nme:</span></i></b><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> En �ok morbidite ve mortaliteye yol a�an ���nc� nedendir. Risk
fakt�rlerine bak&#305;ld&#305;&#287;&#305;nda ya&#351;, hipertansiyon, iskemik
kalp hastal&#305;&#287;&#305;, diyabet, hiperkolesterolemi ve sigara
kullan&#305;m&#305; vard&#305;r. Ya&#351; d&#305;&#351;&#305;nda yukar&#305;da
say&#305;lan nedenler de&#287;i&#351;tirilebilirdir. Ancak bu nedenlerin
aras&#305;nda �ok say&#305;lmayan ve ihmal edilen bir neden de uykudaki solunum
zorluklar&#305;d&#305;r. Hem inme hem de miyokard infarkt�s� i�in risk
say&#305;lmaktad&#305;r. Uyku apne bozuklu&#287;unun dola&#351;&#305;m&#305;n
de&#287;i&#351;imine ve vask�ler hasar geli&#351;imesine yol
a�t&#305;&#287;&#305; bilinmektedir.&nbsp; Daimi, &#351;iddetli, y�ksek vol�ml�
solunum eforu ile horlama epidemiyolojik �al&#305;&#351;malarda, di&#287;er
risklerden ba&#287;&#305;ms&#305;z olarak, inme i�in �nemli risk
olu&#351;turmaktad&#305;r. Ki&#351;inin solunum zorlu&#287;u ile horlama
d&#305;&#351;&#305;nda obezite ve g�n i�i uyuklamas&#305; varsa riski daha
belirginle&#351;tiriyor. Apne veya hipopneleri olan ki&#351;ide hipertansiyon
geli&#351;me riski tedavisiz kald&#305;&#287;&#305; s�rece y�ksektir. Apnenin
bitimine yak&#305;n uyanma d�neminde kalp h&#305;z&#305;nda artma, sempatik
otonomik aktivitede ani artma olur. Apnenin d�zelme faz&#305;nda sistemik
tansiyonda ge�ici y�kselme izlenir. Bu gece boyunca devam eden&nbsp; tansiyon
y�kselme d�nemleri, altta yatan solunum zorlu&#287;u tedavi edilmeyince giderek
ki&#351;ide kal&#305;c&#305; hipertansiyon halini al&#305;r. Artan hiperkapni
ile uzam&#305;&#351; apneler ve progresif oksihemoglobin desaturasyonu kardiyak
debiyi ve kalp h&#305;z&#305;n&#305; azaltarak kardiyak aritmiye neden olur.
REM uykusu bu ki&#351;ilerde daha da riskli hale gelir. REM�de farengeal
kaslarda atoni ve kemoresept�r refleks aktivitede&nbsp; apne s�relerinin daha
da uzamas&#305;na neden olur. Hipoksemiye e&#351;lik eden kardiyak ritm
de&#287;i&#351;iklikleri beyinde kan ak&#305;m&#305;n&#305;n
sa&#287;lanmas&#305;n&#305; da etkileyecektir. Hemodinamik rezervlerin k�t�
olmas&#305;na ba&#287;l&#305; olarak iskemik de&#287;i&#351;iklikler
ka�&#305;n&#305;lmazd&#305;r. REM uykusunda artm&#305;&#351; parasempatik
aktivite kalp h&#305;z&#305;n&#305; d�&#351;�r�r, asistollerin ortaya
�&#305;kmas&#305;nn&#305;n ve �zellikle a�&#305;klanamayan ani gece �l�mlerinin
muhtemel nedeni olabilir.&nbsp; Ge�ici iskemik ataklar ve sessiz infarktlar
uykudayken olur. Embolik kaynakl&#305; retinal infarktlar uyku
s&#305;ras&#305;nda ortaya �&#305;kar. Uykuda embolizm,obstr�ktif apne
s&#305;ras&#305;nda torasik negatif bas&#305;n� olu&#351;umuna sekonder
hemodinamik bozukluklar&#305;n olu&#351;mas&#305; ve serebral kan
ak&#305;m&#305;n&#305;n da azalmas&#305;na neden olur. &#304;nme �ncesi
uykudaki solunum zorluklar&#305; inme i�in risk olurken inme sonras&#305;nda da
uykuda solunum zorluklar&#305;n&#305;n g�r�lme prevalans&#305; artar. CPAP veya
BiPAP uygulamas&#305; riski azaltabilir. </span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><i><span lang=TR style='font-size:10.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>&nbsp;N�romusk�ler
Hastal&#305;klar:</span></i></b><span lang=TR style='font-size:10.0pt;
line-height:115%;font-family:Tahoma;mso-ansi-language:TR'> Spesifik olmamakla
birlikte eri&#351;kin ya&#351;ta ba&#351;layan n�romusk�ler
hastal&#305;klar&#305; olanlarda artan yorgunluk, bitkinlik veya bozulmu&#351;
gece uykusu ilk bulgular olabilir.&nbsp; Amiyotrofik lateral skleroz (ALS) i�in
uykuyu reg�le eden alanlar&#305;n etkilendi&#287;i g�sterilememi&#351;tir,
ancak klinik olarak uykuda problemleri g�r�lmektedir. Uykuda solunum
zorlu&#287;u ve UPEHB ili&#351;kili uyanmalar&#305;n olmas&#305; en s&#305;k
bulgulard&#305;r. Frenik sinir tutulumu olmadan solunuma ba&#287;l&#305; uyku
bozukluklar&#305; �nemsizdir. REM uykusunda yo&#287;un hipoventilasyon ve
oksijen desat�rasyonu olur. Ka�&#305;n&#305;lmaz olarak sonu�ta ventilat�r
ihtiyac&#305; olacakt&#305;r. Ancak baz&#305; hastalarda solunum problemi veya
UPEHB olmaks&#305;z&#305;n uyku b�l�nmeleri olabilir. Anksiyete,
depresyon,&nbsp; a&#287;r&#305;, a&#351;&#305;r&#305; sekresyon, t�kr�&#287;�n
bo&#287;aza ka�mas&#305;, fasik�lasyonlar, kramplar ve yatak i�inde tek
ba&#351;&#305;na d�nememek uyku d�zeninin bozulmas&#305;ndaki di&#287;er
fakt�rler olabilir. &nbsp;&nbsp;Bunlar i�inde en s&#305;k
kar&#351;&#305;la&#351;&#305;lan yak&#305;nma ortopnedir. Poliomiyelit hem
santral hem de periferik solunum fonksiyonlar&#305;n&#305; de&#287;i&#351;tirebilir.
Kas atrofisi ve immobiliteye ba&#287;l&#305; kifoskolyoz potansiyel olarak
ventilasyonu k&#305;s&#305;tlar. Anatomik deformitelere ba&#287;l&#305; olarak
kronik a&#287;r&#305; ve sonucunda uyku problemleri ba&#351;layabilir. Bulber
tutulum �st solunum kaslar&#305;n&#305;n etkilenmesine ve pons tegmentumundaki
n�ronlar&#305;n hasarlanmas&#305;nda REM latans&#305;n&#305;n uzamas&#305;na
neden olur. Postpolio sendromunda g�r�len yorgunlu&#287;un, kas zaaf&#305;na
m&#305; yoksa uyku bozuklu&#287;una m&#305; ba&#287;l&#305; oldu&#287;u uyku
incelemeleri yap&#305;lmadan anla&#351;&#305;lamaz. Siringomiyelide ise
santral, mikst veya obstr�ktif tipte apneler g�r�lebilir. Bulber veya y�ksek
servikal yerle&#351;imli siringomiyeli ise hipoventilasyon ve santral apne
geli&#351;iminden sorumludur. Platibazi, Chiari malformasyonlar&#305; da uykuda
solunum zorlu&#287;u yapabilirler. Polin�ropatilerden en �ok herediter motor ve
duysal n�ropati (Charcot-Marie-Tooth hastal&#305;&#287;&#305;) uykuda solunum
zorlu&#287;una farengeal veya diyafragmatik tutulum ile neden olur. Klinik
olarak obstr�ktif apne ve �st solunum yolu rezistans&#305; &#351;eklinde
s&#305;k kar&#351;&#305;la&#351;&#305;l&#305;r. N�rom�sk�ler kav&#351;ak
hastal&#305;klar&#305;ndan en s&#305;k miyastenia gravisde diyafragma
zaaf&#305;na sekonder uykuda solunum zorlu&#287;u olur. �zellikle restriktif
akci&#287;er sendromu, g�n i�i alveolar hipoventilasyonu ve diyafragma
zaaf&#305; olanlarda risk artmaktad&#305;r. Ya&#351;la birlikte total
akci&#287;er kapasitesinin azalmas&#305;, g�n i�i kan gazlar&#305;n&#305;n
anormal olmas&#305; REM uykusunda hipopne veya apnelerin geli&#351;mesine yol
a�ar. Konjenital miyastenik sendromlar, botulizm, hipermagnezemi ve kene
paralizisi de uyku problemi yarat&#305;rlar. Dispne, sabah ba&#351;
a&#287;r&#305;s&#305;, paroksismal nokt�rnal dispne, b�l�nm�&#351; uyku ve g�n
i�i somnolans di&#287;er klinik bulgulard&#305;r. Kas
hastal&#305;klar&#305;ndan miyotonik distrofide solunum kaslar&#305;n&#305;n
yan&#305; s&#305;ra farengeal ve larengeal kaslar da tutulur.
A&#351;&#305;r&#305; uyuma vard&#305;r. Bu hastalarda dorsal rafe nukleusu ve
superior santral nukleusta serotonin kayb&#305; ve hipotalamik hipokretin
sisteminde fonksiyon bozuklu&#287;u olmas&#305; ile hipersomni ve MULT�de
anormal sonu�lar g�sterir.&nbsp; Alveolar hipoventilasyon REM uykusunda ortaya
�&#305;kar.&nbsp; Hem obstr�ktif hem de santral tipte uyku apnesi vard&#305;r.
Di&#287;er miyopatilerden konjenital ve metabolik miyopatiler hem uyku hem de
solunum zorlu&#287;u yarat&#305;rlar. </span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><i><span lang=TR style='font-size:10.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'>Epilepsi:</span></i></b><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> &#304;nme ve Alzheimer hastal&#305;&#287;&#305;ndan sonra en �ok g�r�len
���nc� n�rolojik hastal&#305;kt&#305;r. Uyku, uyku hastal&#305;klar&#305; ile
epilepsinin s&#305;kl&#305;kla ili&#351;ki i�inde oldu&#287;unu g�sterir. Uyku
ve uyku deprivasyonuun hem parasomnileri&nbsp; hem de n�bet aktivitesini
artt&#305;rd&#305;&#287;&#305; iyi bilinmektedir. NREM uyku n�betlerin ortaya
�&#305;k&#305;&#351;&#305;n&#305; kolayla&#351;t&#305;r&#305;rken, REM uykusu
antiepileptik etki g�sterir. N�betler sonras&#305;nda hipersomni, insomni ve
parasomniler g�r�lebilir. �zellikle OUAS olan ki&#351;ilerde n�betlerin kontrol
alt&#305;na al&#305;nmas&#305; g��le&#351;ebilir. Antiepileptik ila�lar&#305;n
yan etkisi olarak hipersomni g�r�lebilir. Ay&#305;r&#305;c&#305; tan&#305;da
OUAS, narkolepsi, veya idyopatik hipersomni d&#305;&#351;lanmal&#305;d&#305;r.</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;text-transform:uppercase;mso-ansi-language:TR'>Sirkadyen
ritm uyku bozukluklar&#305;</span></b><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Endojen sirkadyen ritm ile �evresel
fakt�rler aras&#305;ndaki uyumun bozulmas&#305; ile ortaya �&#305;kar.
Memelilerde sirkadyen ritmi sa&#287;layan hipotalamustaki suprakiyazmatik
n�kleuslard&#305;r. Sirkadyen ritim i�in en g��l� senkronizasyonu sa&#287;layan
etmen &#305;&#351;&#305;kt&#305;r. &nbsp;I&#351;&#305;k d&#305;&#351;&#305;nda
melatonin, fiziksel ve sosyal aktivitelerde rol oynamaktad&#305;rlar. Faz
kaymas&#305; s&#305;ras&#305;nda melatonin &#305;&#351;&#305;&#287;&#305;n tam
tersi etki g�sterir. Ak&#351;am�zeri verilen melatonin sirkadyen ritmin
ilerlemesine, sabah erken d�nemde verilmesi ise gecikmesine neden olur.
Sirkadyen ritm ile 24 saatlik fizik �evre veya i&#351; ve sosyal
programlar&#305;n aras&#305;nda uyumsuzluk ba&#351;lad&#305;&#287;&#305;nda
sirkadyen ritm uyku faz&#305; bozukluklar&#305; daha s&#305;k olmak �zere
ba&#351;lar. Bitkiler, hayvanlar ve hatta tek h�creli canl&#305;lar&#305;n bile
metabolik aktivite, hareketlilik, beslenme ve di&#287;er fonksiyonlar&#305;
i�in g�nl�k d�zenleri vard&#305;r. T�m canl&#305;larda bu intrensek ritmi
sa&#287;layan sirkadyen ritim vard&#305;r. Bu ritmin bir�ok de&#287;i&#351;keni
vard&#305;r.&nbsp; Yap&#305;lan �al&#305;&#351;malarda &#305;s&#305;, uyku,
serum sodyum, potasyum ve kalsiyum d�zeyi, idrar �&#305;k&#305;&#351;&#305;,
l�kosit say&#305;s&#305;, dikkat, hesaplama gibi de&#287;i&#351;kenler
tan&#305;mlanm&#305;&#351;t&#305;r. </span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&nbsp;Fizyolojik sistemlerde
oldu&#287;u gibi hastal&#305;klar&#305;n ortaya �&#305;k&#305;&#351;&#305;nda
da kronobiyolojik etkiler mevcuttur. En s&#305;k g�r�ld�kleri saatler
a�&#305;s&#305;ndan ele al&#305;n&#305;rsa; ast&#305;m krizi, inme ve diyabetik
ketoasidoz olgular&#305; gece saat 03�den sonra g�r�l�r. Anjina ve miyokard
infarkt�s� sabaha kar&#351;&#305; daha s&#305;k izlenir. Osteoartrite ait
&#351;ikayetler ak&#351;am saat 18�den sonra belirir. Serebral hemoraji saat 21
gibi g�r�l�r. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Gecikmi&#351; uyku faz&#305; sendromu:</span></i><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> Uykunun ba&#351;lamas&#305; ve uyan&#305;kl&#305;k zaman&#305;
aras&#305;nda 3-6 saat gecikme olu&#351;ur. Tipik olarak gece saat 02 ile
06�dan �nce uyumakta zorluklar&#305; olur. Uyku s�resi normaldir. Hastalar
ak&#351;am&#305;n ilerleyen saatlerinde kendilerini daha uyan&#305;k
hissettiklerini belirtirler. Bu ki&#351;iler&nbsp; uyan&#305;kl&#305;k
d�neminde kalmaya zorlan&#305;rsa,&nbsp; kronik olarak gece uyku
yetersizli&#287;i ve g�n i�inde a&#351;&#305;r&#305; uyumalar&#305; olur.
Ergenlerde bu sendrom okul ba&#351;ar&#305;s&#305;zl&#305;&#287;&#305;na,
eri&#351;kinlerde i&#351; performans&#305;n&#305;n bozulmas&#305;na, parasal
zorluklara ve evlilik sorunlar&#305;na yol a�abilir. Tan&#305;y&#305; koymak
i�in en az 7 g�n uyku g�nl�&#287;� tutulmal&#305; veya aktigrafi
yap&#305;lmal&#305;d&#305;r. Uyku zaman&#305;ndaki gecikme g�sterilmelidir.
Nokt�rnal PSG di&#287;er uyku patolojilerini d&#305;&#351;lamak i�in bazen
gerekebilir. V�cut &#305;s&#305;s&#305; ve melatoninin plazma veya t�k�r�kten
�l��m� ile laboratuar olarak tan&#305;y&#305; destekler. Tedavide ama�
sirkadyen i� ritmi tekrar senkronize hale getirmektir. Hastalar kronoterapi
kullan&#305;m&#305; kadar &#305;&#351;&#305;k tedavisinden
faydalan&#305;rlar.&nbsp; Ekzojen melatonin endojen sirkadyen ritmi
de&#287;i&#351;tirebilir. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&#304;lerlemi&#351; uyku faz&#305;
sendromu:</span></i><b><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'> </span></b><span lang=TR
style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'>Beklenen uyku ve uyan&#305;kl&#305;k d�neminin 3 saatten daha fazla erkene
kaymas&#305; ile ortaya �&#305;kar. Ak&#351;am&#305;n erken saatlerinde �n�ne
ge�ilemez uyku nedeniyle kendisinden beklenen ak&#351;am aktivitelerine
kat&#305;lamaz. Tipik �rnek televizyon kar&#351;&#305;s&#305;nda ak&#351;am
yeme&#287;i sonras&#305; �n�ne ge�ilemeyen uykusunun olmas&#305;d&#305;r.
Gecikmi&#351; uyku faz&#305;na g�re g�n i�indeki faaliyetlere
kat&#305;lmas&#305;nda daha az sorunla kar&#351;&#305;la&#351;&#305;rlar.
Tan&#305; i�in gecikmi&#351; uyku faz&#305;na bak&#305;n&#305;z. Tedavide
baz&#305; zorluklar vard&#305;r. Kronoterapiye h&#305;zla n�ks
geli&#351;ebilir. I&#351;&#305;k tedavisi ve melatonin verilmesi ile ilgili
bilgi birikimi fazla de&#287;ildir.</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0cm 0cm 14.0pt 0cm'>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>D�zensiz uyku
uyan&#305;kl&#305;&#287;&#305;n ortaya �&#305;kard&#305;&#287;&#305; di&#287;er
durumlar aras&#305;nda vardiyal&#305; i&#351; uyku bozuklu&#287;u ve �jetlag�
say&#305;labilir.</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

</div>

<p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;text-transform:uppercase;mso-ansi-language:TR'>Parasomni</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>&#304;stenmeyen ve ho&#351; olmayan,
�o&#287;unlukla uykuda ya&#351;anan basit veya kompleks motor, otonomik veya
davran&#305;&#351;larla karakterize olan durumlard&#305;r. Ancak uyanma,
k&#305;smi uyanma ve uyku evre ge�i&#351;i s&#305;ras&#305;nda da g�r�lebilir.
Otonom sinir sistemi ve iskelet sistemi bulgular&#305; �n planda etkilenir.&nbsp;
Ta&#351;ikardi, pupillerde dilatasyon, terleme olur. Primer ve sekonder olarak
iki gruba ayr&#305;l&#305;r. Normal insanlarda da NREM ve REM�de parasomniler
g�r�l�r (<b>Tablo 12</b>).</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span lang=TR style='font-size:12.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Tablo 12. Primer parasomniler</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>REM </span></b></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Normal</span></b></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Kabus</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></b></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Uyku paralizisi</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></b></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Hipnogojik ve hipnopompik hal�sinasyonlar</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Anormal</span></b></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>REM uyku davran&#305;&#351; bozuklu&#287;u</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>REM ile ili&#351;kili sin�s arresti</span><span lang=FI style='mso-ansi-language:
  FI'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span><span lang=FI style='mso-ansi-language:FI'><o:p></o:p></span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Uyku ile ili&#351;kili a&#287;r&#305;l&#305; ereksiyon</span><span
  lang=FI style='mso-ansi-language:FI'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>NREM</span></b></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Normal</span></b></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Hipnogojik d�&#351;ler</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:9'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></b></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Uykuda s&#305;�rama</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:10'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Anormal</span></b></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Konf�zyonel uyanma</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:11'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></b></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Uyurgezerlik</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:12'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Propriospinal miyoklonus</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:13'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Di&#287;er </span></b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>(her uyku evresinde g�r�lebilen durumlar)</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:14'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Bruksism</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:15'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>En�rezis</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:16'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Ritmik hareket bozuklu&#287;u</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:17'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Periyodik ekstremite hareket bozuklu&#287;u</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:18'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Posttravmatik stres bozuklu&#287;u</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:19;mso-yfti-lastrow:yes'>
  <td width=307 valign=top style='width:230.3pt;border:solid black 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>&nbsp;</span></p>
  </td>
  <td width=307 valign=top style='width:230.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
  TR'>Uykuda konu&#351;ma</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>NREM Uykusu Parasomnileri</span></b></p>

<p class=MsoNormal><i><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>Konf�zyonel uyanma:</span></i><span lang=TR style='font-family:Tahoma;
mso-ansi-language:TR'> �ocuklarda s&#305;k g�r�l�r. Klinik olarak yava&#351;
ba&#351;lay&#305;p k�t�le&#351;ir. Yatakta �&#305;rp&#305;nma hareketleri ve
durdurulamayan, teskin edilemeyen a&#287;lamalar olur. �Uyku
sarho&#351;lu&#287;u� varyasyonu olarak d�&#351;�n�lebilir. Eri&#351;kinlerde
prevalans&#305; %4�t�r. Yorgun bir g�n�n ard&#305;ndan s&#305;kl&#305;kla
uyuduktan bir saat sonra g�r�l�r. Tetikleyici olarak kulak infeksiyonu, grip,
ate&#351;, t&#305;kanm&#305;&#351; burun, uyku apnesi say&#305;labilir. S�resi
5 ile 15 dakika aras&#305;ndad&#305;r, ancak 45 dakikaya kadar uzayabilir. Uyku
ter�r�nden ay&#305;rmak gereklidir. Uyku ter�r� ani
ba&#351;lang&#305;�l&#305;d&#305;r. Konf�zyonel uyanma, y�ksek d�zeyde stresli
d�nemde sessiz, uyumlu, duygular&#305;n&#305; a�&#305;&#287;a vurmayan okul
�a&#287;&#305; �ocuklar&#305;nda s&#305;kt&#305;r. Nadiren tedavi gerekir.. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>Uyku ter�r�:</span></i><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp; Uykudan korkun� bir �&#305;&#287;l&#305;k ile aniden ve �ok
korkmu&#351; bir &#351;ekilde a&#287;layarak uyan&#305;r. Ba&#351;&#305;n&#305;
duvara �arpma, etrafta ko&#351;ma veya yataktan d�&#351;me gibi motor bulgular
olabilir. Genellikle selim olmakla birlikte kendini a&#287;&#305;r
yaralayabilir. Uyan&#305;k g�r�nmesine kar&#351;&#305;n konf�zyondad&#305;r.
Sabah uyand&#305;&#287;&#305;nda olanlar&#305;n hepsine kar&#351;&#305;
amneziktir. Uykuda y�r�me ile beraber g�r�lmesi s&#305;kl&#305;kla rastlanan
bir durumdur. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>Uykuda y�r�me:</span></i><span lang=TR style='font-family:Tahoma;
mso-ansi-language:TR'> �ocuklarda prevalans&#305; %1-17 aras&#305;nda iken
eri&#351;kinlerde yakla&#351;&#305;k %4�d�r. Sakin y�r�y�&#351; ile ajite
ko&#351;ma aras&#305;nda de&#287;i&#351;en derecelerde kompleks
davran&#305;&#351;lar sergilerler. Uyan&#305;km&#305;&#351; gibi g�r�n�r,
buzdolab&#305;ndan yemek al&#305;p yer, kap&#305;lar&#305;n kilitlerini a�ar,
evi terk eder. Genellikle konu&#351;mas&#305; anla&#351;&#305;lmazd&#305;r. Bu
ki&#351;ileri uyand&#305;rmak olduk�a zordur. PSG en iyi tan&#305; koydurucu
ara�t&#305;r. &nbsp;&nbsp;</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>Ritmik hareket bozuklu&#287;u</span></i><b><span lang=TR style='font-family:
Tahoma;mso-ansi-language:TR'>:</span></b><span lang=TR style='font-family:Tahoma;
mso-ansi-language:TR'> Eskiden �jactatio capitis nocturna� diye bilinen
genellikle ba&#351; ve boyun kaslar&#305;n&#305;n tekrarlay&#305;c&#305;
stereotipik hareketleridir. Ba&#351;&#305; anteroposterior olarak vurma/�arpma
ile yaralanma olur. Diz ve ellerinin �st�nde iken v�cutta sallanma, bir yandan
di&#287;er yana yuvarlanmalar g�zlenir. Nadir olmakla birlikte subdural
hematom, korneal abrazyon, retinal pete&#351;iler olabilir. Epilepsi
ay&#305;r&#305;c&#305; tan&#305;da d�&#351;�n�lmelidir. &nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>REM Uykusu Parasomnileri<br>
</span></b><i><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>REM uyku davran&#305;&#351;
bozuklu&#287;u:</span></i><span lang=TR style='font-size:10.0pt;line-height:
115%;font-family:Tahoma;mso-ansi-language:TR'> Eri&#351;kin ya&#351;ta g�r�len
bir parasomnidir. REM uykusunda beklenen atoninin olmamas&#305; ile canl&#305;
r�yalara e&#351;lik eden ve �o&#287;unlukla tehlikeli motor hareketlerin
e&#351;lik etti&#287;i ataklard&#305;r. Ataklar&#305;n s&#305;kl&#305;&#287;&#305;
de&#287;i&#351;ken olmakla birlikte haftada birka� kez ile gecede birka� kez
olabilir. En tipik olarak kendine ve yata&#287;&#305;
payla&#351;t&#305;&#287;&#305; ki&#351;iye zarar veren hareketler yapar.
Kendisine sald&#305;r&#305;lmas&#305;, kendisinin sald&#305;rmas&#305; veya
ka�maya �al&#305;&#351;t&#305;&#287;&#305; &#351;eklinde kabusu sabah en ince
detay&#305;na kadar hat&#305;rlar. Erkeklerde kad&#305;nlara g�re daha s&#305;k
g�r�l�r. G�r�lme ya&#351;&#305; 50 ya&#351; sonras&#305;d&#305;r. PSG�de REM
evresinde artm&#305;&#351; kas aktivitesinin g�sterilmesi ve EEG�de n�bet
aktivitesinin olmamas&#305; tan&#305; koydurucudur. &#304;dyopatik
olabilece&#287;i gibi n�rodejeneratif hastal&#305;klarda da ( Parkinson
hastal&#305;&#287;&#305;, Lewy cisimcikli demans ve multisistem atrofi &nbsp;ve
di&#287;er tip demanslarda) g�r�lebilir. Ba&#351;ka n�rolojik
hastal&#305;klardan sonra ortaya �&#305;kabilir. &#304;nme, subaraknoid kanama
ve Guillain-Barr� sendromu say&#305;labilir. Patofizyolojik olarak dopaminerjik
striatal fonksiyon bozuklu&#287;u olabilece&#287;i ileri s�r�lmektedir. Akut
formlar&#305;nda ani alkol veya sedatif-hipnotiklerin
b&#305;rak&#305;lmas&#305; neden olarak g�r�l�r. Trisiklik antidepresanlar, MAO
inhibit�rleri ve serotonin gerial&#305;m inhibit�rlerinin kullan&#305;m&#305;
s&#305;ras&#305;nda da ortaya �&#305;kan olgular vard&#305;r. Tedavide
klonazepam etkindir. Yatarken 0.5-1 mg (0.25-4mg) al&#305;nmas&#305;
yeterlidir.&nbsp; Ancak uzun d�nem ya&#351;l&#305; ki&#351;ilerde benzodiazepin
kullan&#305;m&#305;n&#305;n kognitif fonksiyonlara k�t� etkisi olabilir.
Di&#287;er alternatif tedaviler karbamazepin, L-dopa ve dopamin agonistleridir.
Klonazepama g�re etkinlikleri daha azd&#305;r. </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Kabus:</span></i><span lang=TR
style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> &nbsp;R�ya g�rd�&#287;� s&#305;rada REM uykusundan gecenin ikinci
yar&#305;s&#305;nda korkmu&#351; olarak uyan&#305;r. Uyan&#305;k ve
r�yan&#305;n t�m detay&#305;n&#305; hat&#305;rlar ve anlat&#305;r. Uyku ter�r�
gecenin ilk yar&#305;s&#305;nda NREM uykuda ve otonomik bulgular&#305;n&#305;n
�ok belirgin olmas&#305; ve ertesi sabah olay&#305; hat&#305;rlamamas&#305; ile
kabuslardan ayr&#305;l&#305;r. </span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>REM ile ili&#351;kili sin�s arresti :</span></i><b><span
lang=TR style='font-size:10.0pt;line-height:115%;font-family:Tahoma;mso-ansi-language:
TR'> </span></b><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Asistoller 9 saniyeye kadar
uzayabilir. Patofizyolojisinde otonomik fonksiyon bozuklu&#287;u vard&#305;r. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;line-height:115%;
font-family:Tahoma;mso-ansi-language:TR'>Sekonder parasomniler ise uykuda
spesifik organa ba&#287;l&#305; olarak anormal veya a&#351;&#305;r&#305;
otonomik/fizyolojik olaylar&#305;n g�r�lmesidir. </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt'><b><span lang=TR
style='font-family:Tahoma;text-transform:uppercase;mso-ansi-language:TR'>Kaynaklar</span></b></p>

<p class=MsoNormal style='margin-left:54.0pt;text-indent:-18.0pt'><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>1.</span><span lang=TR
style='font-size:7.0pt;line-height:115%;font-family:"Times New Roman";
mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Carney PR, Berry RB, Geyer JD.
Clinical Sleep Disorders. Lippincott Williams &amp; Wilkins 2005</span></p>

<p class=MsoNormal style='margin-left:54.0pt;text-indent:-18.0pt'><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>2.</span><span lang=TR
style='font-size:7.0pt;line-height:115%;font-family:"Times New Roman";
mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Guillenminault C. Clinical
Neurophysiology of Sleep Disorders. Handbook of clinical neurophysiology series
eds Daube JR, Mauguiere F. vol 6 Elsevier 2005 </span></p>

<p class=MsoNormal style='margin-left:54.0pt;text-indent:-18.0pt'><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>3.</span><span lang=TR
style='font-size:7.0pt;line-height:115%;font-family:"Times New Roman";
mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Kryger MH, Roth T, Dement WC.
Principles and Practice of Sleep Medicine. Elsevier Saunders 4th edition 2005.</span></p>

<p class=MsoNormal style='margin-left:36.0pt'><span lang=TR style='font-family:
Tahoma;mso-ansi-language:TR'>&nbsp;</span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:36.0pt'><span lang=TR style='font-family:
Tahoma;mso-ansi-language:TR'>&nbsp;</span></p>

</div>

</body>

</html>
